{"text": "Results : .Greater than or equal to grade 3 acute toxicity is very low for all patients : less than 1 % for group 1 , less than 3 % for group 2 , and less than 10 % for group 3 patients .", "label": "", "metadata": {}, "score": "23.393187"}
{"text": "Toxicity .Grades 1 and 2 GI acute toxicity were identified in 29 ( 20 % ) and 2 ( 1.4 % ) patients , respectively .", "label": "", "metadata": {}, "score": "23.879353"}
{"text": "The incidence of acute grade 2 gastrointestinal and genitourinary toxicity was 36 % and 44 % , respectively .The authors compared these toxicity results with a historical control group treated with conventional radiotherapy fractionation and found that the hypofractionation group experienced greater grade 1 to 2 toxicity ( .", "label": "", "metadata": {}, "score": "26.97086"}
{"text": "There was 1 % grade 3 acute urinary toxicity , but no grade 3 acute rectal toxicity .At 5 years , the combined grade 2 to 4 late rectal toxicity was 4.5 % .", "label": "", "metadata": {}, "score": "27.353237"}
{"text": "However , the grade of toxicity was low , and most patients had grade 1 .On the other hand , acute GI toxicity was not frequently observed in either group , as was previously reported [ 5 , 9 , 11 ] .", "label": "", "metadata": {}, "score": "27.862286"}
{"text": "There were no statistically significant differences in late toxicity between the 2 arms .The incidence of late grade 3 or higher genitourinary or gastrointestinal toxicity was 1 % and 2 % , respectively .", "label": "", "metadata": {}, "score": "29.531456"}
{"text": "Grade 3 or higher GU toxicity was detected in 4 % of patients .Conclusions : Acute GU and GI toxicity were comparable with other series .", "label": "", "metadata": {}, "score": "29.964054"}
{"text": "No grade 3 or greater toxicities were recorded .Maximum GI toxicity was grade 0 , 1 , and 2 in 69 % , 23 % , and 8 % , respectively .", "label": "", "metadata": {}, "score": "30.501183"}
{"text": "During treatment or within the first 90 days after treatment , acute grade 2 GI toxicity occurred in 65 ( 56.03 % ) and grade 3 GI toxicity in 3 patients ( 2.59 % ) .", "label": "", "metadata": {}, "score": "30.640572"}
{"text": "Maximum GI toxicity was grade 0 , 1 , and 2 in 69 % , 23 % , and 8 % , respectively .One patient reported grade 2 enteritis using oral anti - diarrheal medication .", "label": "", "metadata": {}, "score": "31.40574"}
{"text": "Results : No Grade 3 or 4 GI side effects were observed .Grades I and 2 rectal GI toxicity occurred in 36 % , and 38 % , respectively .", "label": "", "metadata": {}, "score": "31.865067"}
{"text": "Seven ( 1.9 % ) patients developed late Grade 3 urinary retention requiring urethrotomy for urethral strictures .Another four ( 1.1 % ) patients developed late Grade 3 gastrointestinal toxicity , two of whom had endoscopically verified Grade 3 rectal mucositis .", "label": "", "metadata": {}, "score": "32.546204"}
{"text": "Zelefsky also reported similar results [ 9 ] .Ohashi et al . also reported that the predictive parameter of grade 2 or higher GI toxicity was the maximal rectal dose in multivariate analysis [ 4 ] .", "label": "", "metadata": {}, "score": "32.68785"}
{"text": "Out of 101 evaluable patients , 9 % experienced late grade 2 urinary toxicity , and 1 % experienced late grade 3 urinary toxicity .The authors reported no grade 3 rectal toxicity .", "label": "", "metadata": {}, "score": "32.857933"}
{"text": "No grade 4 or greater GU toxicity was observed .The 5-year actuarial likelihood of late grade 2 or 3 GU toxicities was 6.3 % [ Figure 3 ] .", "label": "", "metadata": {}, "score": "33.605183"}
{"text": "Toxicity was scored per event with 4.8 % acute Grade 3 genitourinary and no acute Grade 3 gastrointestinal toxicity .Late Grade 3 genitourinary and gastrointestinal toxicity were respectively 3.4 % and 1.4 % .", "label": "", "metadata": {}, "score": "33.974155"}
{"text": "We encountered 3.4 % late Grade 3 genitourinary toxicity with seven patients developing strictures requiring urethrotomy .Late Grade 3 rectal morbidity was 1.4 % overall with one patient requiring endoscopic restoration of bowel continuity after rectal biopsy associated ulcer development .", "label": "", "metadata": {}, "score": "34.05922"}
{"text": "Severe late GU toxicity of grade 2 occurred in 8 patients ( 5.76 % ) and grade 3 in 6 patients ( 7.41 % ) .", "label": "", "metadata": {}, "score": "34.132553"}
{"text": "However , there was no difference in overall survival between the two arms .Acute genitourinary toxicity was higher in the hypofractionated arm with 9 % versus 5 % grade 3 or higher .", "label": "", "metadata": {}, "score": "34.284103"}
{"text": "No acute grade 3 or 4 toxicities were observed .The grade 2 GU acute toxicity was significantly lower in the hypofractionated arm : 19.1 % versus 47.7 % ( . )", "label": "", "metadata": {}, "score": "35.430885"}
{"text": "Acute toxicities were scored using the RTOG / EORTC criteria and the international prostate symptom index .None of the patients experienced grade 3 - 4 toxicity .", "label": "", "metadata": {}, "score": "35.664772"}
{"text": "Corresponding figures for Grades 1 and 2 GU toxicity were 42\\% and 39\\% , respectively .Grade 3 or higher GU toxicity was detected in 4\\% of patients .", "label": "", "metadata": {}, "score": "35.86627"}
{"text": "Acute GI grade 1 and grade 2 toxicities were 30 % and 14 % , respectively .The three - year actuarial biochemical control rate was 97 % .", "label": "", "metadata": {}, "score": "36.561516"}
{"text": "No grade 3 or higher toxicities were observed .The authors concluded that the regimen was effective and safe .Furthermore , Soete et al .", "label": "", "metadata": {}, "score": "36.570465"}
{"text": "No grade 4 GI or GU late toxicity was observed .Conclusions .These medium - term results demonstrate a good tolerance of high - dose image - guided IMRT .", "label": "", "metadata": {}, "score": "37.009632"}
{"text": "The grouping of responses considered was : high toxicity ( grade 2 - 3 ) vs. low or no toxicity ( grades 1 or 0 ) .", "label": "", "metadata": {}, "score": "37.0346"}
{"text": "Rectal hemorrhage as a grade 3 late GI toxicity occurred in two patients who were treated with several transfusions and a laser cauterization procedure .No grade 4 or greater GI complications were observed .", "label": "", "metadata": {}, "score": "37.0855"}
{"text": "Acute grade 2 GU symptoms occurred in 20 - 30 % of patients .Actuarial rectal bleeding at 2 years did not differ significantly between fractional dose levels .", "label": "", "metadata": {}, "score": "37.195248"}
{"text": "Table 4 .The univariate and multivariate analyses in predicting acute GU , late GU and late GI toxicity of grade 2 or greater in all patients .", "label": "", "metadata": {}, "score": "38.35063"}
{"text": "There were no late grade 5 GI toxicity - suffering patients in this group .Pretreatment GU damage of grade 2 was found in the history of 4 patients ( 3.44 % ) and grade 3 in the history of 2 patients ( 1.72 % ) .", "label": "", "metadata": {}, "score": "39.39553"}
{"text": "Similar observation was made for late GI toxicity ( only 5 cases of grade 3 , 1 of grade 4 , and no instances of grade 5 ) and for late GU toxicity ( only 13 patients of grade 3 and none of grade 4 or 5 ) .", "label": "", "metadata": {}, "score": "39.669064"}
{"text": "Alicikus et al . reported a grade 2 acute GU toxicity frequency of 3 % .Nevertheless , other studies have indicated higher occurrences of grade 2 acute GU toxicity than our study , ranging from 22 to 47 % [ 3 , 4 , 16 ] .", "label": "", "metadata": {}, "score": "39.701138"}
{"text": "The incidence of late grade 2 - 3 GU toxicities appeared to be lower than that previously reported [ 1 , 4 , 16 , 20 ] .", "label": "", "metadata": {}, "score": "39.772377"}
{"text": "Using our fractionation scheme Jabbari et al .[21 ] reported a higher grade 2 late toxicity , but a lower grade 3 late toxicity .", "label": "", "metadata": {}, "score": "39.782265"}
{"text": "Prior to radiotherapy , 3 patients ( 3.77 % ) had grade 2 toxicity , and none had grade 3 GU toxicity .Acute grade 2 GU toxicity developed in 20 ( 24.69 % ) and grade 3 in 1 ( 1.23 % ) patients .", "label": "", "metadata": {}, "score": "39.925957"}
{"text": "Grade 2 acute and late complications appear to be higher in group 3 patiens than in group 1 and 2 patients .Dose - volume analysis of the bladder and rectum to predict the risk of grade 3 or 4 acute and late toxicity is planned .", "label": "", "metadata": {}, "score": "40.07792"}
{"text": "The GI toxicity was limited to increased stool frequency and necessity of using adult diapers which resolved by all ( 2 ) patients within 6 months .", "label": "", "metadata": {}, "score": "40.129128"}
{"text": "ratio of 1.5 .At the median follow - up of 41 months , there were no instances of grade 3 GI toxicity and only a single episode of acute grade 3 GU toxicity .", "label": "", "metadata": {}, "score": "40.477425"}
{"text": "Acute toxicity .The mean IPSS before treatment was 9/35 , did not increase in the acute phase .The percentages of grade 2 and 3 acute GI toxicity were 12 % and 2 % , respectively .", "label": "", "metadata": {}, "score": "40.549263"}
{"text": "Univariate and multivariate analyses were conducted for factors associated with toxicity .Results .In the WP group , an increase of acute rectal toxicity was observed .", "label": "", "metadata": {}, "score": "40.760735"}
{"text": "No Grade 4 or higher acute or late toxicities occurred .Erectile dysfunction Grade 3 , defined as a medically assisted erectile dysfunction inadequate for intercourse , was reported by 19 ( 5.4 % ) patients prior to BRT .", "label": "", "metadata": {}, "score": "40.961708"}
{"text": "There was no acute RTOG grade 3 or 4 toxicity .At 2 years , there were 4 % grade 2 GI and 4.25 % grade 2 GU toxicity .", "label": "", "metadata": {}, "score": "41.526833"}
{"text": "Although there were initial grade 2 toxicities ( 13 % GU and 7 % GI ) , these scores returned to or improved over baseline at 6 months .", "label": "", "metadata": {}, "score": "41.73629"}
{"text": "These regimens were designed to maintain equivalent predicted late toxicity of approximately 76 Gy in 38 fractions .When the tumor . of 1.5 Gy is assumed , the 2 Gy equivalent dose is estimated to be 82 Gy .", "label": "", "metadata": {}, "score": "42.821907"}
{"text": "The rates of grade 1 , 2 , and 3 acute GU toxicities were 29 % , 31 % , and 5 % , respectively .", "label": "", "metadata": {}, "score": "42.90323"}
{"text": "The late grade 2 GI toxicity was 3 % during 24 months FU .Genitourinary ( GU ) grade 2 , 3 toxicity was seen in 15 % , 8 % , in the acute phase and 10 % , 6 % at 24 months , respectively .", "label": "", "metadata": {}, "score": "42.959644"}
{"text": "None of the patients in the PO group suffered grade 2 , 3 or 4 pretreatment GI disorders .During RT or within the first 90 days after PO 3DCRT , acute grade 2 GI toxicity occurred in 21 cases ( 25.93 % ) , and there were no patients with grade 3 or 4 GI toxicity .", "label": "", "metadata": {}, "score": "42.985146"}
{"text": "Only 6 patients developed grade 3 toxicity ( 3 patients : acute GU , 3 patients : late GU ) .No patients developed grade 3 GI toxicity .", "label": "", "metadata": {}, "score": "43.18961"}
{"text": "Late toxicity is low compared to historical controls : 2 patients have demonstrated late grade 3 GU toxicity .No patients have been reported with greater than or equal to grade 3 late rectal complications .", "label": "", "metadata": {}, "score": "43.22431"}
{"text": "[28 ] presented in their study similar results as our ones in the occurrence of severe late GU toxicity ( grades 2 - 3 ) , and even worse outcomes in evolution of acute GU toxicity .", "label": "", "metadata": {}, "score": "43.601368"}
{"text": "None of the patients in the cohort had grade 4 of GU toxicity .Figure 1 summarizes the proportion of evolution of GI ( Figure 1A ) and GU ( Figure 1B ) toxicity events from pretreatment through acute to late damage , for both the WP and PO patient groups .", "label": "", "metadata": {}, "score": "43.75248"}
{"text": "There was no acute GI and GU toxicity grade 3 or higher .Late grade 2 or 3 GI toxicities developed in eight patients ( 5.7 % ) at a median of 18 months after image - guided IMRT .", "label": "", "metadata": {}, "score": "44.324444"}
{"text": "At median follow - up of 2.7 years , there were no grade 4 toxicities .RTOG grade 3 , 2 , and 1 bladder toxicities were seen in 3 % ( 2 patients ) , 5 % ( 3 patients ) , and 23 % ( 13 patients ) , respectively .", "label": "", "metadata": {}, "score": "44.42073"}
{"text": "Biochemical failure was defined according to the Phoenix Consensus and toxicity evaluated using the Common Toxicity Criteria for Adverse Events version 3 .Results .The median follow - up time was 59.3 months .", "label": "", "metadata": {}, "score": "44.891182"}
{"text": "However , further follow - up and examination is necessary to evaluate late GU toxicity and related factors .In this series , acute grade 2 GU toxicity was statistically related to late grade 2 - 3 GU toxicity in the MA [ Table 3 .", "label": "", "metadata": {}, "score": "44.96881"}
{"text": "Patients were treated with 56 Gy in 16 fractions over 4 weeks .Acute toxicity was scored weekly during treatment and I and 2 months after treatment using the Radiation Therapy Oncology Group / European Organization for Research and Treatment of Cancer criteria extended with additional symptoms and the International Prostate Symptom Index ( IPSS ) .", "label": "", "metadata": {}, "score": "44.99029"}
{"text": "Correlation with a number of clinical and dosimetric parameters was assessed by univariate and multivariate analyses .Results : No Grade 3 or 4 GI side effects were observed .", "label": "", "metadata": {}, "score": "45.265877"}
{"text": "Late toxicity included 4.2 % RTG grade 2 rectal , 7.8 % grade 2 urinary , and 1.4 % grade 3 urinary .Mean Expanded Prostate Cancer Index Composite ( EPIC ) score for urinary and bowel QOL declined at 1 month post - treatment and returned to baseline by 2 years .", "label": "", "metadata": {}, "score": "45.545094"}
{"text": "Toxicity .Table 3 shows the distribution of acute toxicity for the total group of 351 patients .Part of the data was presented at the 2007 German Society of Radiation Oncology meeting [ 21 ] .", "label": "", "metadata": {}, "score": "45.940323"}
{"text": "The median follow - up was 60 months .Results .There was no grade 3 or 4 acute toxicity .The incidence of grade 2 acute gastrointestinal ( GI ) and genitourinary ( GU ) toxicities were 1.4 % and 8.5 % , respectively .", "label": "", "metadata": {}, "score": "46.057064"}
{"text": "Abbreviations : G I , gastrointestinal ; GU , genitourinary ; NA , not applicable ; other abbreviations as in Tables 1 - 2 .Late grade 2 or 3 GU toxicities developed in nine patients ( 6.4 % ) at a median of 30 months after image - guided IMRT .", "label": "", "metadata": {}, "score": "46.369675"}
{"text": "In UA , the group without ADT was related to grade 2 or 3 late GI toxicities , whereas that relationship was not significant in MA [ Table 3 ] .", "label": "", "metadata": {}, "score": "46.99836"}
{"text": "Keyes et al . also reported that the IPSS was the most significant factor by the RTOG score [ 7 ] .On the other hand , there were no significant factors predicting grade 2 or higher acute GI toxicity in our study , because there were only a few patients who developed grade 2 or higher acute GI toxicity .", "label": "", "metadata": {}, "score": "47.20523"}
{"text": "The relationship of the applied dose and the percentage of volume of bone marrow irradiated are presented in Figure 2 .The highest correlation occurred at a dose of 46 Gy , as depicted in Figure 3 .", "label": "", "metadata": {}, "score": "47.24627"}
{"text": "The rates of biochemical failure using the Nadir+2 ng / mL definition and clinical failure , consisting of either local - regional failure or distant metastasis ( LRF / DM ) , and deaths without failure were reported .", "label": "", "metadata": {}, "score": "47.393852"}
{"text": "The median follow - up was 32 and 35 months in the hypofractionation and conventional fractionation arms , respectively .No difference was found for late toxicity between the two treatment groups .", "label": "", "metadata": {}, "score": "47.51272"}
{"text": "The GI toxicity was lower in both hypofractionated treatment arms : 3.6 % in the 60 Gy group and the 1.4 % in the 57 Gy group .", "label": "", "metadata": {}, "score": "47.526054"}
{"text": "The only predictive factor for late GI toxicity in our present study was R100 .This result was comparable to previous reports [ 6 , 8 , 9 , 11 ] .", "label": "", "metadata": {}, "score": "47.62221"}
{"text": "Each patient received magnetic resonance imaging before the initial treatment to exclude lymph node metastasis and for the staging procedure .Patients with T2b or T2c clinical stage tumors , a Gleason score ( GS ) of 7 , or a pretreatment PSA level between 10 and 20 ng / mL were classified as intermediate - risk disease .", "label": "", "metadata": {}, "score": "48.01818"}
{"text": "Toxicity and QoL was assessed prospectively using validated questionnaires .Results .Median follow - up was 23 months .The 2-year actuarial biochemical control rate was 100 % .", "label": "", "metadata": {}, "score": "48.052635"}
{"text": "[20 ] ; however , some investigators did n't demonstrate this correlation [ 21 ] .On the other hand , the diminution of late GI and GU toxicities to grade 1 or to no toxicity in the majority of acute toxicity ( grade 1 - 3 ) suffering patients , was observed also in the WP 3DCRT group .", "label": "", "metadata": {}, "score": "48.109787"}
{"text": "The 5-year , biochemical progression free survival ( bPFS ) for level 1 was 94.7 % , with no difference between fractionation dose schedules ( .", "label": "", "metadata": {}, "score": "48.135044"}
{"text": "The authors observed differences in toxicity depending on the treatment regimen .More specifically , acute rectal toxicity was worse in the hypofractionated arm , while late urinary and rectal toxicity were reported as equivalent but were not quantified .", "label": "", "metadata": {}, "score": "48.141083"}
{"text": "Maximum grade toxicity rates were compared .Statistical analysis .Statistical analyses were conducted using Stata version 11 software ( StataCorp , College Station , TX ) .", "label": "", "metadata": {}, "score": "48.175125"}
{"text": "Acute and late toxicity data were scored according to the National Cancer Institute - designated Common Terminology Criteria for Adverse Events Version 4.0 .Statistical analyses .", "label": "", "metadata": {}, "score": "48.27018"}
{"text": "All patients tolerated the ERB throughout the entire treatment course .Pretreatment demographics are listed in Table 1 .The majority of patients had clinical stage T1c , Gleason 6 or 7 disease , median PSA 7.6 , mean age 68 , mean prostatic volume 45 cc , and mean IPSS 8 .", "label": "", "metadata": {}, "score": "48.28939"}
{"text": "S80-S81 , 2009 .View at Google Scholar .C. Menkarios , T. Vigneault , N. Brochet et al . , \" Toxicity report of once weekly radiation therapy for low - risk prostate adenocarcinoma : preliminary results of a phase I / II trial , \" Radiation Oncology , vol .", "label": "", "metadata": {}, "score": "48.36477"}
{"text": "Heemsbergen WD , Peeters ST , Koper PC , Hoogeman MS , Lebesque JV : Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients : consequential late damage .", "label": "", "metadata": {}, "score": "48.448128"}
{"text": "Pre - existing hemorrhoid history has varied in significance in prior ERB studies .In the Baylor report , patients with pre - existing anorectal disease had a higher risk of developing acute anorectal toxicity ; 43 % with pre - existing history of anorectal disease vs. 16 % without reported acute grade 2 GI toxicity [ 14 ] .", "label": "", "metadata": {}, "score": "48.621513"}
{"text": "Only the 45 Gy group demonstrated sustained PSA and tumor volume decreases in most mice [ 65 ] .This preclinical data supported the clinical trial launched by Boike and colleagues at UTSW [ 59 ] , who conducted a phase I study that escalated the total doses from 45 Gy to 50 Gy in 5 fractions .", "label": "", "metadata": {}, "score": "48.847942"}
{"text": "used the same fractionation scheme ( 5 fractions ) as Freeman [ 16 ] and reported 5 % and 3.5 % for grade 2 and 3 GU late toxicity , respectively .", "label": "", "metadata": {}, "score": "49.21702"}
{"text": "Summary of GI and GU symptoms scoring before and after 3DCRT .Patients were scored according to the modification of RTOG morbidity scale .Percentage of occurrence of grades G0 , G1 , G2 , and G3 of pretreatment pathology , acute , and late GU and GI toxicities are demonstrated .", "label": "", "metadata": {}, "score": "49.403652"}
{"text": "[ 3 ] reported on a group of 197 patients with a four - year BC rate of 87 % in 86 high risk - cases .", "label": "", "metadata": {}, "score": "49.512512"}
{"text": "After an initial dose - finding period , patients received daily fractions of 3.3 Gy equivalent , 4 days per week to a total dose of 66 Gy equivalent .", "label": "", "metadata": {}, "score": "49.68669"}
{"text": "In this trial , the 5-year rate of failure ( biochemical or clinical ) was higher in the hypofractionated arm compared to the standard fractionation arm ( 60 % versus 53 % , .", "label": "", "metadata": {}, "score": "49.721546"}
{"text": "Pollack et al .[14 ] reported results of a hypofractionated trial in patients with intermediate to high - risk features .The fractional dose was 2.7 Gy per treatment .", "label": "", "metadata": {}, "score": "49.77014"}
{"text": "Most important from a clinical point of view and the overall quality of life of prostate cancer patients after 3DCRT treatment was the diminution of late GI and GU toxicity to grades 0 - 1 in a majority of acute toxicities of patients suffering grades 1 - 3 .", "label": "", "metadata": {}, "score": "49.798462"}
{"text": "The average months at risk after completion of radiation ranged from 33 - 37 for patients at dose level 1 and 19 - 29 for patients at dose level 2 .", "label": "", "metadata": {}, "score": "49.82514"}
{"text": "Several series reported toxicities between 3 % and 20 % [ 17 - 19 ] .Fowler . et al .[20 ] mentioned the influence of treatment time for high fraction dose on the log cell kill ( BED ) suggested a decrease in the BED for fraction duration of more than 30 minutes .", "label": "", "metadata": {}, "score": "50.057266"}
{"text": "Patients were treated to total dose of 70 Gy in 28 daily fractional dose of 2.5 Gy .Biochemical failure , using both the ASTRO consensus definition [ 51 ] and the RTOG Phoenix definition ( nadir+2 ng / mL ) [ 52 ] , was the study endpoint .", "label": "", "metadata": {}, "score": "50.057747"}
{"text": "View at Google Scholar . E. E. K. Yeoh , R. J. Fraser , R. E. McGowan et al . , \" Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma : early results of a Phase III randomized trial , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "50.26346"}
{"text": "ranging from 1.2 to 4 have been reported , while most data support values at the lower end of this spectrum [ 6 - 13 ] .", "label": "", "metadata": {}, "score": "50.32103"}
{"text": "Int J Radiat Oncol Biol Phys 2006 , 64 : 527 - 533 .PubMed View Article .Snyder KM , Stock RG , Hong SM , Lo YC , Stone NN : Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose - volume histogram analysis .", "label": "", "metadata": {}, "score": "50.34567"}
{"text": "All patients were treated to their prescribed dose in daily 2.0 Gy fractions .The imaging dose was not accounted for in the treatment plans .", "label": "", "metadata": {}, "score": "50.366665"}
{"text": "In their initial acute toxicity report of the first 100 patients treated with IMRT utilizing an ERB air , the Baylor group found no relationship between acute rectal toxicity and rectal mean dose or rectal V65 , V70 , and V75 [ 18 ] .", "label": "", "metadata": {}, "score": "50.37088"}
{"text": "Low - risk patients had clinical stage of T1 or T2 , PSA less than or equal to 10 , and Gleason score less than 7 .", "label": "", "metadata": {}, "score": "50.643448"}
{"text": "Zelefsky et al .indicated more severe late urinary toxicity following high - dose IMRT delivering 81.0 Gy or 86.4 Gy [ 25 ] .Therefore , we began setting the urethral dose constraints in 2004 .", "label": "", "metadata": {}, "score": "50.653988"}
{"text": "[ 24 , 25 ] , Freeman et al .[26 ] and other authors [ 27 ] reported milder toxicity profiles in comparison with our results , particularly in the case of late GI and GU impairments .", "label": "", "metadata": {}, "score": "50.72425"}
{"text": "The acute rectal toxicity scores were 0 in 20 , 1 in 61 , and 2 in 19 patients .A great majority of patients experienced grade 0 - 1 acute gastrointestinal ( GI)/genitourinary ( GU ) toxicities .", "label": "", "metadata": {}, "score": "50.807304"}
{"text": "In contrast , similar to Alicikus et al . , the use and duration of ADT was not related to the late grade 2 - 3 GU toxicity in this study [ 1 ] [ Table 3 .", "label": "", "metadata": {}, "score": "50.824623"}
{"text": "There was no acute GI or GU toxicity of grade 3 or higher .Similar to Alicikus et al . , the acute GI toxicity was minimal [ 1 ] .", "label": "", "metadata": {}, "score": "50.884514"}
{"text": "Finally , combination with EBRT remained in the multivariate analysis .Regarding late GI toxicity , BED , R100 , % RD 30 and combination with EBRT remained in the univariate analysis .", "label": "", "metadata": {}, "score": "50.89993"}
{"text": "CLINICAL AND DOSIMETRIC PREDICTORS OF ACUTE TOXICITY AFTER A 4-WEEK HYPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY REGIMEN FOR PROSTATE CANCER : RESULTS FROM A MULTICENTRIC PROSPECTIVE TRIAL .", "label": "", "metadata": {}, "score": "51.065887"}
{"text": "Three - dimensional conformal radiotherapy and IMRT were allowed .Mature results of the study are not yet available .The dose per fraction was 2.625 Gy , slightly higher than the fractional dose used by Kupelian et al .", "label": "", "metadata": {}, "score": "51.14017"}
{"text": "Figures 2 , 3 , 4 , 5 , 6 , 7 and 8 shows the results of each comparison of GU and GI toxicity regarding hematuria , miction pain , urinary incontinence , urinary frequency / urgency , urinary retention , proctitis , and rectal bleeding .", "label": "", "metadata": {}, "score": "51.14608"}
{"text": "Results .Biochemical tumor - control rate .Distant metastasis - free survival , cause - specific survival and overall survival rates .Distant metastases developed in four ( 2.8 % ) patients .", "label": "", "metadata": {}, "score": "51.17959"}
{"text": "There were several patients who developed G3 urinary retention in the monotherapy group .Overall , 8 of all the patients developed acute urinary retention during the follow - up period .", "label": "", "metadata": {}, "score": "51.4535"}
{"text": "The 5-year actuarial distant metastasis - free survival , CSS , and OS rates were also evaluated by Kaplan - Meier curves .MA was performed using a Cox regression model .", "label": "", "metadata": {}, "score": "51.80378"}
{"text": "The results of toxicity dynamics are summarized in Table 3 .The values of the last late GI and GU toxicity observed in patients during their last inspection are shown .", "label": "", "metadata": {}, "score": "51.93377"}
{"text": "Similarities were found between our results , the RTOG 9413 [ 22 ] analysis , and the GETUG-01 [ 23 ] prospective study .The diversity in the diagnostics could be created by individual physicians due to the subjectivity of the scoring system , when the same toxicity could be graded differently .", "label": "", "metadata": {}, "score": "51.994595"}
{"text": "Conclusions .The boost group showed higher incidence rates of both GU and GI toxicity .Higher IPSS before seed implantation , combination with EBRT and a higher R100 were significant predictors for acute GU , late GU and late GI toxicity .", "label": "", "metadata": {}, "score": "52.02716"}
{"text": "The objective of the trial primary endpoint was a comparison preliminary report focused on early toxicity using the RTOG / European Organization for Research and Treatment of Cancer ( EORTC ) acute toxicity grading system .", "label": "", "metadata": {}, "score": "52.03794"}
{"text": "PubMed View Article .Heemsbergen WD , Peeters ST , Koper PC , Hoogeman MS , Lebesque JV : Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients : consequential late damage .", "label": "", "metadata": {}, "score": "52.047726"}
{"text": "In all patients , PSA control was 100 % by the Phoenix definition .In light of the accumulating clinical evidence for hypofractionation , RTOG 0938 [ 66 ] has been initiated in the USA It is a prospective randomized phase II trial that will compare 36.25 Gy in 5 fractions of 7.25 Gy to 51.6 Gy in 12 fractions of 4.3 Gy .", "label": "", "metadata": {}, "score": "52.06567"}
{"text": "Ritter et al .[ 24 ] reported a preliminary analysis of toxicity with hypofractionated radiotherapy at the 2006 ASTRO meeting .This collaborative effort reported on 110 patients treated with image - guided IMRT to a total dose of 64.68 Gy in 2.94 Gy fractions given 4 to 5 days per week .", "label": "", "metadata": {}, "score": "52.140324"}
{"text": "View at Google Scholar .C. I. Tang , D. A. Loblaw , P. Cheung et al . , \" Phase I / II study of a five - fraction hypofractionated accelerated radiotherapy treatment for low - risk localised prostate cancer : early results of pHART3 , \" Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "52.412586"}
{"text": "6 , pp .469 - 475 , 2009 .View at Google Scholar \u00b7 View at Scopus .G. Soete , S. Arcangeli , G. De Meerleer et al . , \" Phase II study of a four - week hypofractionated external beam radiotherapy regimen for prostate cancer : report on acute toxicity , \" Radiotherapy and Oncology , vol .", "label": "", "metadata": {}, "score": "52.416954"}
{"text": "Many investigators [ 2 - 14 ] have reported adverse events after LDR - brachytherapy .In some studies the adverse events were assessed by the RTOG or RTOG / EORTC scale [ 2 - 8 ] , and in others , by the NCI - CTCAE scale [ 9 - 13 ] .", "label": "", "metadata": {}, "score": "52.43194"}
{"text": "Late complications were defined as those developing more than 90 days after the last treatment .Acute and late toxicities were scored according to RTOG and LENT - SOMA morbidity scale ( grades 1 - 5 ) .", "label": "", "metadata": {}, "score": "52.544266"}
{"text": "Emerging radiobiological data indicates that prostate cancer has a low a / \u03b2 -ratio of 1.2 - 3.0 Gy [ 22 - 24 ] , suggesting that biological dose escalation can be achieved by hypofractionated treatment schemes .", "label": "", "metadata": {}, "score": "52.546623"}
{"text": "Conclusions .SBRT to 38 Gy in 4 daily fractions for low- and intermediate - risk PC patients is feasible with low acute and late genitourinary and gastrointestinal toxicity .", "label": "", "metadata": {}, "score": "52.55087"}
{"text": "The study included 36 patients treated with 56 Gy in 16 fractions ( 3.5 Gy per fraction ) over 4 weeks , 4 fractions per week , using 3-dimentional conformal radiation therapy or IMRT .", "label": "", "metadata": {}, "score": "52.55667"}
{"text": "Acute Maximum GU and GI Toxicities with IMRT using a water - filled endorectal balloon .GU toxicity .Maximum GU toxicity was grade 2 ( 42 % ) , grade 1 ( 41 % ) , and grade 0 ( 17 % ) .", "label": "", "metadata": {}, "score": "52.751823"}
{"text": "To elucidate an independent factor among clinical and postdosimetric parameters to predict grade 2 or higher GU and GI toxicity in the acute and late phases , univariate and multivariate logistic regression analyses were carried out .", "label": "", "metadata": {}, "score": "52.76851"}
{"text": "Patients from the PO group received a dose of 60 Gy in 30 fractions to the PTV2 .Then the PTV3 received the prescribed dose of 10 - 18 Gy in 5 - 9 fractions .", "label": "", "metadata": {}, "score": "52.88083"}
{"text": "All acute and late complications were significantly less than predicted by comparable patients from previous RTOG studies .Authors ' Conclusions .Tolerance to 3D conformal radiation therapy in RTOG 9406 remains better than expected despite dose escalation .", "label": "", "metadata": {}, "score": "52.89666"}
{"text": "The therapy was generally well tolerated , and few patients had late complications .More specifically , two patients developed rectal strictures , and a few patients had recurrent rectal bleeding episodes .", "label": "", "metadata": {}, "score": "52.967"}
{"text": "Patients with a T4 clinical stage tumor , the presence of metastasis , other concurrent invasive cancers , or active collagen disease were also not included .", "label": "", "metadata": {}, "score": "52.982304"}
{"text": "Acute toxicity was defined as symptoms that had completely resolved by six months after BRT .Adverse events that persisted or appeared beyond six months were considered late toxicity .", "label": "", "metadata": {}, "score": "52.98841"}
{"text": "In our current cohort , 10 patients were treated with a weekend rest of 2 days between the four fractions due to logistic reasons .These 10 patients did not show a lower rectal or bladder toxicity .", "label": "", "metadata": {}, "score": "53.10081"}
{"text": "References .Mark R , Anderson P , Akins R : Interstitial high - dose - rate brachytherapy as monotherapy for early stage prostate cancer : Median 8-year results in 301 patients .", "label": "", "metadata": {}, "score": "53.120895"}
{"text": "The PSA control rate was 90 % by the Phoenix definition .Tang et al .[ 55 ] used slightly higher dose per fraction ( 7 Gy ) to treat 30 men a phase I / II study .", "label": "", "metadata": {}, "score": "53.125595"}
{"text": "The list of predictive factors was the same for acute and late toxicities ; except for the addition of acute toxicity , as the next predictive factor of late OAR damage .", "label": "", "metadata": {}, "score": "53.170662"}
{"text": "However , the 3-year freedom from biochemical failure rates were 87 % and 79 % in the hypofractionation and conventional fractionation groups , respectively ( .", "label": "", "metadata": {}, "score": "53.198036"}
{"text": "Note : The results are presented as mean \u00b1 standard deviation .Discussion .This study is the first to our knowledge to report the acute toxicity of prostate cancer patients treated with IG - IMRT using an ERB H2O .", "label": "", "metadata": {}, "score": "53.25482"}
{"text": "The 5-year CSS rates for the intermediate- and high - risk patients were both 100 % .The 5-year OS rates for the intermediate- and high - risk patients were 100 and 91.7 % , respectively .", "label": "", "metadata": {}, "score": "53.34107"}
{"text": "A total of 218 patients with a median follow - up of 42.5 months were enrolled .The patients were divided into 2 groups by treatment modality , namely , the monotherapy group ( 155 patients ) and the boost group ( 63 patients ) .", "label": "", "metadata": {}, "score": "53.35639"}
{"text": "Rogers et al .[ 8 ] reported a BC rate of 94 % at five years in 284 intermediate - risk patients treated with two implants at three fractions of 6.5 Gy .", "label": "", "metadata": {}, "score": "53.41204"}
{"text": "4 , pp .1153 - 1160 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Soete , S. Arcangeli , G. De Meerleer et al . , \" Phase II study of a four - week hypofractionated external beam radiotherapy regimen for prostate cancer : report on acute toxicity , \" Radiotherapy and Oncology , vol .", "label": "", "metadata": {}, "score": "53.6047"}
{"text": "In addition , the duration between ADT initiation and the start of IMRT was not correlated with late GI grade 2 or 3 toxicities [ Table 3 .", "label": "", "metadata": {}, "score": "53.609093"}
{"text": "Finally the PTV3 received the prescribed dose 6 - 10 Gy in 3 - 5 fractions .Dose volume histograms ( DVH ) were generated for all PTVs and OARs .", "label": "", "metadata": {}, "score": "53.62169"}
{"text": "In 14 patients ( 28 % ) , a visible dominant tumor was detected on the contrast - enhanced MRI with a mean tumor volume of 1.2 cc ( range , 0.46 - 4.1 cc ) .", "label": "", "metadata": {}, "score": "53.818424"}
{"text": "Results .Table 1 shows patient characteristics .The MRI staging was : T1c ( 9 , 18 % ) , T2a ( 22 , 44 % ) , T2b ( 4 , 8 % ) , T2c ( 2 , 4 % ) , T3a ( 13 , 26 % ) .", "label": "", "metadata": {}, "score": "53.893616"}
{"text": "In this study , we evaluated the GU and GI toxicity in patients who underwent LDR - brachytherapy , not only in the acute and late phases , but also in each period after seed implantation using the NCI - CTCAE .", "label": "", "metadata": {}, "score": "54.000404"}
{"text": "All models were statistically significant and adequately interpolated the data ; however in both models for late toxicities , GI and GU , a large disparity between the number of patients in groups with high toxicity vs. low or no toxicity was observed .", "label": "", "metadata": {}, "score": "54.117867"}
{"text": "Toxicity analysis for gastrointestinal and genitourinary sites was performed using the National Cancer Institute Common Toxicity Criteria for Adverse Events , version 3 .Follow - up for this analysis was completed during October 2010 .", "label": "", "metadata": {}, "score": "54.167248"}
{"text": "The incidence rates of urinary incontinence , urinary frequency / urgency rectal bleeding and proctitis in the boost group were significantly higher than those in the monotherapy group .", "label": "", "metadata": {}, "score": "54.377476"}
{"text": "PubMed View Article .Skazikis G , Kurek R , Baltas D : Acute toxicity of HDR - brachytherapy as monotherapy for low - risk cancer : Analysis of 297 patients treated with two different fractionation schemes .", "label": "", "metadata": {}, "score": "54.695457"}
{"text": "Dosimetric data assessing specifically acute GI toxicity associations and rectal parameters are also limited in the non - ERB IMRT setting .As the QUANTEC report recently summarized , most of the mature published clinical data on dose - related rectal toxicity come from non - ERB 3DCRT and focus on either cumulative or late toxicity , concluding that the high - dose regions are most predictive [ 19 ] .", "label": "", "metadata": {}, "score": "54.702423"}
{"text": "Toxicity within 90 days after radiotherapy was considered acute toxicity , and toxicity after 90 days was considered late toxicity .The IPSS , the PR-25 and the IIEF questionnaires were used to asses the GU , GI functional QoL , and erectile function .", "label": "", "metadata": {}, "score": "54.77575"}
{"text": "The dose levels are as follows : I. 68.4 Gy , II .73.8 Gy , III .79.2 Gy .All doses are prescribed to the minimum isodose line covering the PTV .", "label": "", "metadata": {}, "score": "54.873833"}
{"text": "With the median follow - up of 44.5 months , none of the patients experience biochemical failure by Phoenix ( nadir+2 ) definition .Thirteen patients experienced PSA bounces .", "label": "", "metadata": {}, "score": "55.016933"}
{"text": "The 3-year freedom from biochemical failure rates were 87 % and 79 % in the hypofractionation and conventional fractionation groups , respectively ( . )", "label": "", "metadata": {}, "score": "55.081795"}
{"text": "There were no significant differences in acute GU and GI toxicity between the two groups , while late GU and GI toxicity were significantly higher in the boost group .", "label": "", "metadata": {}, "score": "55.094696"}
{"text": "In our patients , an excellent early PSA nadir was achieved .This is comparable to HDR and EBRT series with longer FU [ 5 , 13 ] .", "label": "", "metadata": {}, "score": "55.113136"}
{"text": "Regarding late GI toxicity , R100 was a significant parameter .Abbreviations .International Prostate Symptom Score .BED : .Biologically effective dose .ADT : .", "label": "", "metadata": {}, "score": "55.19102"}
{"text": "The median follow - up was 66 months ( range : 17 - 111 months ) .Freedom from biochemical relapse was analyzed using the Phoenix consensus definition ( i.e. , an absolute nadir PSA level plus 2 ng / mL more than the recorded level ) [ 7 , 8 ] .", "label": "", "metadata": {}, "score": "55.28135"}
{"text": "Group 1 consisted of patients with T1/2 tumors with SVI risk less than 15 % .Group 2 consisted of patients with T1/2 tumors with SVI risk greater than or equal to 15 % .", "label": "", "metadata": {}, "score": "55.290016"}
{"text": "3.0 grading , and were compared between the monotherapy group and the boost group .This study was performed in compliance with the Helsinki Declaration .", "label": "", "metadata": {}, "score": "55.48191"}
{"text": "For functional scales , higher scores represent better QoL. For symptom scales , higher scores indicate more symptoms or more problems .In our cohort , there was a significant increase in the urinary symptoms in the first year which was reversed at 24 months .", "label": "", "metadata": {}, "score": "55.482903"}
{"text": "An added complexity is that it is not clear whether the traditional linear quadratic model continuing to model closely the radiation dose - response in tumors applies for fractional doses in the range of 6 - 8 Gy or higher [ 36 - 38 ] .", "label": "", "metadata": {}, "score": "55.485382"}
{"text": "Attempting to phase these weaknesses , Brenner et al .[ 7 ] performed another post hoc analysis of a prospective dose escalation trial that combined external beam radiotherapy and HDR brachytherapy in men treated at a single institution .", "label": "", "metadata": {}, "score": "55.603428"}
{"text": "For comparison of immune parameters between the group of patients suffering from any acute and late GU or GI toxicity ( T ) , and the group of patients without toxicity side effects ( 0 ) after 3DCRT the t - test was applied .", "label": "", "metadata": {}, "score": "55.611164"}
{"text": "Although Smeenk et al . reported some procedures for reducing the physiological bowel effects , those techniques were not used in this study [ 21 ] .", "label": "", "metadata": {}, "score": "55.65532"}
{"text": "According to previous studies , biochemical tumor - control rate improvement will lead to better distant metastasis - free survival and CSS [ 13 - 15 ] .", "label": "", "metadata": {}, "score": "55.88042"}
{"text": "Usually , adverse events are evaluated in the acute and late phases using the Radiation Therapy Oncology Group ( RTOG ) scale [ 2 - 8 ] or the National Cancer Institute ( NCI ) Common Terminology Criteria for Adverse Events ( CTCAE ) [ 9 - 13 ] .", "label": "", "metadata": {}, "score": "55.97079"}
{"text": "Soete et al .[ 23 ] used even higher dose per fraction , 3.5 Gy , to treat 36 patients in a phase II trial .", "label": "", "metadata": {}, "score": "56.139305"}
{"text": "A 7-Year Experience .Int J Radiat Oncol Biol Phys 2012 .Demanes DJ , Martinez AA , Ghilezan M , Hill DR , Schour L , Brandt D , Gustafson G : High - Dose - Rate Monotherapy : Safe and Effective Brachytherapy for Patients with Localized Prostate Cancer .", "label": "", "metadata": {}, "score": "56.173233"}
{"text": "These comparative rates for acute GI toxicity are summarized in Table 5 .While PTV margins were the same in our ERB and non - ERB cohorts , in these initial 100 patients treated with a water - filled balloon and IG - IMRT , more stringent constraints were implemented for the bladder and rectum in this cohort and may explain the more favorable toxicity profile .", "label": "", "metadata": {}, "score": "56.21341"}
{"text": "The standard 5 - 8 coplanar beams were used .The prescribed dose used to cover 95 % of the target volume ( D 95 ) was 76 Gy in 13 patients and 80 Gy in 128 patients .", "label": "", "metadata": {}, "score": "56.28853"}
{"text": "Results .Clinical outcome .Of the 351 patients , 21 ( 5.9 % ) developed biochemical relapses with five ( 1.4 % ) developing distant metastatic disease .", "label": "", "metadata": {}, "score": "56.29751"}
{"text": "Only 18 patients ( WP-7.76 % and PO-11.11 % ) suffered severe late GI toxicity , and 26 patients ( WP-11.21 % and PO-16.05 % ) severe late GU toxicity .", "label": "", "metadata": {}, "score": "56.306396"}
{"text": "11 - 18 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Norkus , A. Miller , J. Kurtinaitis et al . , \" A randomized trial comparing hypofractionated and conventionally fractionated three - dimensional external - beam radiotherapy for localized prostate adenocarcinoma : AAAAA report on acute toxicity , \" Strahlentherapie und Onkologie , vol .", "label": "", "metadata": {}, "score": "56.308315"}
{"text": "All patients were seen every 3 months in the first year and subsequently twice yearly .Statistical analysis .The GI and GU toxicity were evaluated according to the EORTC - RTOG toxicity scores , using a combination of the patients ' questionnaires and physicians ' charts .", "label": "", "metadata": {}, "score": "56.362434"}
{"text": "23 , no .25 , pp .6132- 6138 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Pollack , A. L. Hanlon , E. M. Horwitz et al . , \" Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "56.474987"}
{"text": "A total of 218 patients who were clinically diagnosed with localized prostate cancer ( cT1c-2cN0M0 ) and who underwent LDR - brachytherapy between July 2004 and November 2008 were enrolled in this prospective study .", "label": "", "metadata": {}, "score": "56.4912"}
{"text": "We await increased numbers and follow - up for further analysis including biochemical control , correlates with acute and eventually late toxicity , and comparison to non - ERB patients .", "label": "", "metadata": {}, "score": "56.534004"}
{"text": "If the dominant tumor was visible on the MRI , an integrated boost to the visible tumor was planned up to 11 Gy / fraction which is 120 % of the prescribed dose ( PD ) .", "label": "", "metadata": {}, "score": "56.632504"}
{"text": "In our cohort , Gleason score , pre - treatment PSA , and clinical stage did not attain statistical significance using Kaplan - Meier actuarial estimates of freedom from biochemical failure .", "label": "", "metadata": {}, "score": "56.649773"}
{"text": "The purpose of this study was to compare the toxicity and efficacy of hypofractionated ( 62 Gy/20 fractions/5 weeks , 4 fractions per week ) versus conventional fractionation radiotherapy ( 80 Gy/40 fractions/8 weeks ) .", "label": "", "metadata": {}, "score": "56.792633"}
{"text": "This prospective , dose escalation trial ( RTOG 9406 ) was initiated to test the feasibility of dose escalation and define the MTD as well as the rate of long term morbidities .", "label": "", "metadata": {}, "score": "56.86199"}
{"text": "Acute and late GI and GU toxicities were studied in order to identify the treatment - related , clinical and patient characteristics that correlated with the severity of complications and disorders .", "label": "", "metadata": {}, "score": "57.02495"}
{"text": "381 - 385 , 1993 .View at Google Scholar \u00b7 View at Scopus .C. Park , L. Papiez , S. Zhang , M. Story , and R. D. Timmerman , \" Universal survival curve and single fraction equivalent dose : useful tools in understanding potency of ablative radiotherapy , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "57.02655"}
{"text": "Most of the studies concerning SBRT as a monotherapy or even as a boost following external beam radiotherapy presented only negligible incidence of severe late GI and GU toxicity .", "label": "", "metadata": {}, "score": "57.086468"}
{"text": "( Table 1 ) .From July 2004 to April 2007 , there were 97 patients who were treated with seed implantation at a prescribed dose of 145 Gy , and 58 patients were treated at a prescribed dose of 160 Gy after May 2007 .", "label": "", "metadata": {}, "score": "57.11487"}
{"text": "Factors associated with increased GU toxicity included pretreatment AUA symptoms score .Length of ADT did not influence GU toxicity .An Australian trial reported by Yeoh et al .", "label": "", "metadata": {}, "score": "57.13851"}
{"text": "PubMed View Article .Cahlon O , Zelefskym J , Shippy A , Chan H , Fuks Z , Yamada Y , Hunt M , Greenstein S , Amols H : Ultra - high dose ( 86.4 Gy ) IMRT for localized prostate cancer : toxicity and biochemical outcomes .", "label": "", "metadata": {}, "score": "57.188522"}
{"text": "Dose homogeneity was between 95 % and 107 % of the ICRU reference dose .Dose - volume histograms were used for evaluation of doses to target volumes and organs at risk .", "label": "", "metadata": {}, "score": "57.231094"}
{"text": "PubMed View Article .Mohammed N , Kestin L , Ghilezan M , Krauss D , Vicini F , Brabbins D , Gustafson G , Ye H , Martinez A : Comparison of acute and late toxicities for three modern high - dose radiation treatment techniques for localized prostate cancer .", "label": "", "metadata": {}, "score": "57.241516"}
{"text": "One was using external beam radiation therapy and the other was using permanent brachytherapy .The authors used the standard linear - quadratic model and disease - free estimates relied on PSA values .", "label": "", "metadata": {}, "score": "57.412907"}
{"text": "GU and GI toxicity were evaluated using the National Cancer Institute - Common Terminology Criteria for Adverse Events , version 3.0 ( CTCAE ver.3.0 ) at 1 , 3 , and 6 months after seed implantation , and every 6 months thereafter .", "label": "", "metadata": {}, "score": "57.546906"}
{"text": "The mean changes in the EORTC - QLQ PR25 score for each domain are shown in Figure 4 .The median bowel symptoms did not change after the treatment .", "label": "", "metadata": {}, "score": "57.682907"}
{"text": "Eighty percent of the patients potent at baseline remained potent at the time of recent analysis .McBride et al .[58 ] reported a Phase I multi - institutional trial of SBRT , also using the CyberKnife delivery platform .", "label": "", "metadata": {}, "score": "57.68927"}
{"text": "Toxicity .The toxicity percentage was conform literature .Although this group had more GU complaints because of their predisposing factors ( large volume , bad flow , high IPSS , TURP or abdominal surgery ) before the treatment , they did not show more toxicity in the acute neither in the late phase .", "label": "", "metadata": {}, "score": "57.6994"}
{"text": "Primary end - points were feasibility and late GI toxicity by RTOG scale , while secondary end - points included acute GI toxicity , acute and late genitourinary ( GU ) toxicity , biochemical control , and survival .", "label": "", "metadata": {}, "score": "57.70005"}
{"text": "PubMed View Article .Townsend NC , Huth BJ , Ding W , Garber B , Mooreville M , Arrigo S , Lamond J , Brady LW : Acute toxicity after cyberknife - delivered hypofractionated radiotherapy for treatment of prostate cancer .", "label": "", "metadata": {}, "score": "57.756638"}
{"text": "The 5-year rates of any failure for standard fractionation and hypofractionation were 14.4 % and 13.9 % , respectively .There were no statistically significant differences in GI toxicity between the arms .", "label": "", "metadata": {}, "score": "57.765038"}
{"text": "The significance level and odds ratio for statistically significant regression coefficients are summarized in Table 2 for acute and late GI and GU toxicity .Acute GI and GU toxicities were significantly dependent on patients ' increasing age , and the chance of developing high toxicity levels greaten .", "label": "", "metadata": {}, "score": "57.765953"}
{"text": "Of all patients , 78.0 % showed acute GU toxicity , and 7.8 % showed acute GI toxicity , while 63.8 % showed late GU toxicity , and 21.1 % showed late GI toxicity .", "label": "", "metadata": {}, "score": "57.86441"}
{"text": "This study reports our 42-month follow - up results , and evaluates the relationships between pretreatment , acute and late rectal and urinary syndromes and tumor- , patient- and treatment - related factors .", "label": "", "metadata": {}, "score": "57.932632"}
{"text": "Martin et al .[ 18 ] reported a prospective Phase II trial also using 3 Gy per fraction to treat 92 patients between 2001 and 2004 .", "label": "", "metadata": {}, "score": "57.979774"}
{"text": "The 4-year PSA relapse - free survival was 94 % .Katz et al .[ 50 , 64 ] reported an experience of SBRT treatment given to 304 patients with clinically localized prostate cancer .", "label": "", "metadata": {}, "score": "57.995728"}
{"text": "The fractional dose in this trial was 2.75 Gy .Two hundred seventeen patients with T1 - 2 prostate carcinomas were randomized to either the standard or the hypofractionated arm between 1996 and 2006 .", "label": "", "metadata": {}, "score": "58.015347"}
{"text": "This is comparable to the previous reports [ 5 , 7 , 10 , 11 ] .Our previous report has also demonstrated that an objective parameter ( uroflowmetry ) and a subjective parameter ( IPSS ) showed transient deterioration in the first 6 months after seed implantation [ 15 ] .", "label": "", "metadata": {}, "score": "58.042435"}
{"text": "Table 2 : Prospective trials of hypofractionated external - beam radiotherapy ( 5 fractions ) .The first prospective trial of SBRT for prostate cancer was published by Madsen and colleagues [ 53 , 54 ] , who treated 40 patients with SBRT using a daily dose of 6.7 Gy to a total dose of 33.5 ( 6.7 Gy X 5 ) Gy .", "label": "", "metadata": {}, "score": "58.043747"}
{"text": "ratio of 1.5 .The trial compared 76 Gy in conventional 2.0 Gy fractions to 70.2 Gy in 2.7 Gy fractions .The hypofractionated arm was estimated to be equivalent to 84.4 Gy in 2.0 Gy fractions and designed to be equivalent to 8 Gy increase over the standard fractionated total dose of 76 Gy .", "label": "", "metadata": {}, "score": "58.10062"}
{"text": "In addition to high - dose image - guided IMRT , a relatively high rate and long duration of ADT administration may contribute to the current biochemical tumor - control outcome , although the effect was not statistically significant [ Tables 2 and 4 [ 1 , 12 , 16 , 17 ] .", "label": "", "metadata": {}, "score": "58.131752"}
{"text": "ratio of 1.5 Gy .They concluded that the calculated .ratio argued for hypofractionation regimens using high - dose rate ( HDR ) brachytherapy or external beam radiation therapy .", "label": "", "metadata": {}, "score": "58.15638"}
{"text": "Over the last 4 years , 50 hormone - na\u00efve patients with low- and intermediate - risk PC were treated with SBRT to a total dose of 38 Gy delivered in four daily fractions of 9.5 Gy .", "label": "", "metadata": {}, "score": "58.207462"}
{"text": "According to Alicikus et al . , the lack of a benefit from ADT in their high - risk patients may have been caused by the relatively short course of only 5 - 6 months of ADT in their study [ 1 ] .", "label": "", "metadata": {}, "score": "58.23375"}
{"text": "PubMed View Article .Zelefsky ML , Fuks Z , Hunt M , Yamada Y , Marion C , Ling CC , Amols H , Venkatraman ES , Leibel SA : High - dose intensity modulated radiation therapy for prostatic cancer : early toxicity and biochemical outcome in 772 patients .", "label": "", "metadata": {}, "score": "58.255936"}
{"text": "Abstract].Brachytherapy 2010 , 9 : 76 .View Article .Yoshioka Y , Konishi K , Sumida I : Monotherapeutic high - dose - rate brachytherapy for prostate cancer : five - year results of an extreme hypofractionation regimen with 54 Gy in nine fractions .", "label": "", "metadata": {}, "score": "58.39482"}
{"text": "847 - 852 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. P. Kirkpatrick , J. J. Meyer , and L. B. Marks , \" The linear - quadratic model is inappropriate to model high dose per fraction effects in radiosurgery , \" Seminars in Radiation Oncology , vol .", "label": "", "metadata": {}, "score": "58.49945"}
{"text": "3 , no . 3 , pp .127 - 132 , 1991 .View at Google Scholar \u00b7 View at Scopus .T. Akimoto , H. Muramatsu , M. Takahashi et al . , \" Rectal bleeding after hypofractionated radiotherapy for prostate cancer : correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "58.58316"}
{"text": "Cancer 2009 , 115 ( 15 ) : 3446 - 3456 .PubMed View Article .Jani AB , Gratzle J : Late radiotherapy toxicity after prostate cancer treatment : influence of hormonal therapy .", "label": "", "metadata": {}, "score": "58.60064"}
{"text": "concluded that R150 was a significant prognostic factor for rectal bleeding in multivariate analysis [ 6 ] .In our present study , IPSS was the only prognostic factor predicting grade 2 or higher acute GU toxicity in multivariate analysis .", "label": "", "metadata": {}, "score": "58.60874"}
{"text": "24 - 33 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. L. Scrivner , J. S. Meyer , N. Rujanavech , A. Fathman , and T. Scully , \" Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies , \" Journal of Urology , vol .", "label": "", "metadata": {}, "score": "58.689926"}
{"text": "ratio for prostate cancer is widely believed to be in the range 1 - 4 Gy [ 7 - 12 ] .In this context , it has been hypothesized that the therapeutic ratio would be enhanced by increasing the dose per fraction to the prostate cancer above the standard range [ 8 - 12 ] .", "label": "", "metadata": {}, "score": "58.691685"}
{"text": "PubMed View Article .Int J Radiat Oncol Biol Phys 2010 .Sandhu AS , Zelefsky MJ , Lee HJ , Lombardi D , Fuks Z , Leibel SA : Long - term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection .", "label": "", "metadata": {}, "score": "58.6978"}
{"text": "All patients were treated with a minimum of 36 hours between fractions with no more than 3 fractions per week .At the time of the report , the median follow - up was 30 months , 18 months , and 12 months for the 45 Gy , 47.5 Gy , and 50 Gy groups , respectively .", "label": "", "metadata": {}, "score": "58.769745"}
{"text": "King et al .[ 56 , 57 ] reported a follow - up of a phase II trial .The treatment consisted of SBRT with a total dose of 36.25 Gy in 5 fractions using the Cyberknife treatment platform .", "label": "", "metadata": {}, "score": "58.81066"}
{"text": "Bastasch MD , Teh BS , Mai WY , McGary JE , Grant WH , Butler EB : Tolerance of endorectal balloon in 396 patients treated with intensity - modulated radiation therapy ( IMRT ) for prostate cancer .", "label": "", "metadata": {}, "score": "58.84285"}
{"text": "References .Cancer Facts and Figures 2012 , American Cancer Society , 2012 . E. L. Paquette , L. Sun , L. R. Paquette , R. Connelly , D. G. Mcleod , and J. W. Moul , \" Improved prostate cancer - specific survival and other disease parameters : impact of prostate - specific antigen testing , \" Urology , vol .", "label": "", "metadata": {}, "score": "58.914856"}
{"text": "5 , pp .1932 - 1936 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Update of Toxicity Following 3D Radiation Therapy for Prostate Cancer on RTOG 9406 .", "label": "", "metadata": {}, "score": "58.94576"}
{"text": "At a median follow - up of 40 months ( range , 9 - 58 months ) , 10 patients died of other causes and 9 were lost to follow - up .", "label": "", "metadata": {}, "score": "59.036034"}
{"text": "This rate of erectile preservation is consistent with data reported in recent publications on HDR monotherapy [ 8 , 26 , 27 ] .The consistently low level of severe acute and late toxicities in HDR BRT likely reflects the precision of 3D dosimetry , which can reduce uncertainties in dose distribution and thereby allow for better sparing of critical organs [ 28 ] .", "label": "", "metadata": {}, "score": "59.08676"}
{"text": "This analysis confirms the feasibility and safety at 2 to 3 years followup of modest dose escalation with 3D conformal radiation therapy for both early stage and locally advanced prostate cancer .", "label": "", "metadata": {}, "score": "59.10807"}
{"text": "PubMed View Article .Williams SG , Millar JL , Dally MJ , Sia S , Miles W , Duchesne GM : What defines intermediate - risk prostate cancer ?", "label": "", "metadata": {}, "score": "59.21205"}
{"text": "The treatment time was between 55 - 130 minutes , there was no difference between patients with or without boost with a mean of 64 minutes versus 59 minutes , respectively .", "label": "", "metadata": {}, "score": "59.281616"}
{"text": "King CR , Brooks JD , Gill H , Presti JC Jr : Long - term outcomes from a prospective trial of stereotactic body radiotherapy for low - risk prostate cancer .", "label": "", "metadata": {}, "score": "59.289856"}
{"text": "PubMed View Article .Takeshima T , Chamoto K , Wakita D , Ohkuri T , Togashi Y , Shirato H , Kitamura H , Nishimura T : Local radiation therapy inhibits tumor growth through the generation of tumor - specific CTL : its potentiation by combination with Th1 cell therapy .", "label": "", "metadata": {}, "score": "59.30509"}
{"text": "The study population thus consisted of 197 patients .Follow - up evaluations after treatment were performed at 3 to 6 month intervals .The median follow - up was 42 months , ranging from 24 to 55 months .", "label": "", "metadata": {}, "score": "59.518517"}
{"text": "PubMed View Article .Pollack A , Zagars GK , Starkschall G , Antolak JA , Lee JJ , Huang E , von Eschenbach AC , Kuban DA , Rosen I : Prostate cancer radiation dose response : results of them . D. Anderson phase III randomized trial .", "label": "", "metadata": {}, "score": "59.528046"}
{"text": "15 , pp .3681 - 3690 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. P. Boike , Y. Lotan , L. C. Cho et al . , \" Phase I dose - escalation study of stereotactic body radiation therapy for low- and intermediate - risk prostate cancer , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "59.53968"}
{"text": "It is though important to mention that although these two clinical trials show low rates of morbidity , taking into consideration the long natural history of prostate cancer and the heterogeneity of patients within risk groupings , it is difficult to draw inference on treatment efficacy .", "label": "", "metadata": {}, "score": "59.55536"}
{"text": "PBMCs ( 5 \u00d7 10 5 cells / well ) were stained with the antibody mixture for 30 min on ice , washed , and measured with a Becton Dickinson LSRII instrument ( BD Biosciences ) .", "label": "", "metadata": {}, "score": "59.617714"}
{"text": "Thus , the IPSS increased on average 2 points from pre- to immediate post - treatment recording , while the subjective IPSS score on average was unchanged , confirming the tolerability and mild bother of such treatment .", "label": "", "metadata": {}, "score": "59.833145"}
{"text": "Abstract].Strahlenther Onkol 2007 , 183 : 125 .Sondernr 1 .Brenner DJ , Martinez AA , Edmundson GK , Mitchell C , Thames HD , Armour EP : Direct evidence that prostate tumors show high sensitivity to fractionation ( low alpha / beta ratio ) , similar to late - responding normal tissue .", "label": "", "metadata": {}, "score": "59.942833"}
{"text": "At a median followup of 90 months , biochemical relapse - free survival ( bRFS ) was significantly better with hypofractionation when Phoenix definition was used ( 53 % versus 34 % , . )", "label": "", "metadata": {}, "score": "59.964745"}
{"text": "Patients enrolled in the clinical trial over a period of 1964 to 1984 .The trial included men with early ( T1-T2 ) and advanced ( T3-T4 ) disease that were treated by external beam radiotherapy .", "label": "", "metadata": {}, "score": "59.997772"}
{"text": "[26 ] .The authors of this trial compared a conventionally fractionated regimen ( 2 Gy / fraction to 64 Gy ) with a hypofractionated regimen ( 2.75 Gy / fraction to 55 Gy ) .", "label": "", "metadata": {}, "score": "60.0075"}
{"text": "Maturation of these trials and others in development will help to answer several key questions , including the confirmation of the expected improvement in the therapeutic ratio , long - term biochemical relapse free survival , and long - term quality - of - life parameters .", "label": "", "metadata": {}, "score": "60.041336"}
{"text": "ratio is generally assumed to be approximately 10 Gy for most tumors and early - responding normal tissues and less than 5 Gy for late - responding tissues .", "label": "", "metadata": {}, "score": "60.041794"}
{"text": "Final follow - up questionnaires were returned by 344 ( 98 % ) patients during November and December 2010 .Seven ( 2 % ) patients were not alive at the time of reporting .", "label": "", "metadata": {}, "score": "60.131767"}
{"text": "The number of patients with a visible tumor on the MRI was low ( 28 % ) , this could be explain because of the inclusion of more low - risk patient with Gleason - score of 6 which is not always visible on the MRI .", "label": "", "metadata": {}, "score": "60.148277"}
{"text": "The AUA GU symptom score increases returned to baseline in the 45-Gy and 50-Gy group but persisted in the 47.5-Gy dose level patients .", "label": "", "metadata": {}, "score": "60.17171"}
{"text": "Patients in the hypofractionated groups received either 60 Gy in 20 fractions or 57 Gy in 19 fractions .All treatments were 5 fractions per week .", "label": "", "metadata": {}, "score": "60.39451"}
{"text": "Tabi Z , Spary LK , Coleman S , Clayton A , Mason MD , Staffurth J : Resistance of CD45RA- T cells to apoptosis and functional impairment , and activation of tumor - antigen specific T cells during radiation therapy of prostate cancer .", "label": "", "metadata": {}, "score": "60.406204"}
{"text": "Results were also reported according to prognostic groups .For low , intermediate and high - risk disease , the 5-year bRFS rates using ASTRO consensus definition were 97 % , 88 % , and 70 % .", "label": "", "metadata": {}, "score": "60.44564"}
{"text": "Based on the observed difference between the 2 groups , the investigators derived an estimate of 1.2 Gy ( 95 % confidence interval , 0.03 - 4.1 ) for .", "label": "", "metadata": {}, "score": "60.49869"}
{"text": "Next year we will start a phase III trial to compare this SBRT schemes with the standard EBRT of 39\u00d72 Gy to address outcomes , toxicity and QoL. Conclusions .", "label": "", "metadata": {}, "score": "60.57016"}
{"text": "UCLA index data showed a slight improvement in urinary function at 2 years compared with pretreatment .LENT / SOMA assessments demonstrated worsening of bowel function at 2 years .", "label": "", "metadata": {}, "score": "60.59395"}
{"text": "877 - 882 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. M. McBride , D. S. Wong , J. J. Dombrowski et al . , \" Hypofractionated stereotactic body radiotherapy in low - risk prostate adenocarcinoma : preliminary results of a multi - institutional phase 1 feasibility trial , \" Cancer , vol .", "label": "", "metadata": {}, "score": "60.595345"}
{"text": "[ 31 ] .The biological variables and different clinical decisions based on patient age could participate on the final outcome .The association of acute GU toxicity with the percentage of the urinary bladder receiving 50 Gy found in our study was in accordance with the results of Fiorino et al .", "label": "", "metadata": {}, "score": "60.647934"}
{"text": "The second category includes clinical trials of hypofractionated regimens that did not depend on the .ratio hypothesis .The third category includes prospective phase I to II studies using fractionation regimens that assumed that the .", "label": "", "metadata": {}, "score": "60.672096"}
{"text": "Discussion .SBRT is increasingly used because of the possibility of this image - guided technique to minimize the margins needed for treatment , reducing normal tissue dose and resulting in a lower percentage of toxicity .", "label": "", "metadata": {}, "score": "60.685616"}
{"text": "The different dose levels and fractionation schemes between series could also be a reason for differences in toxicity records Table 2 shows toxicity of published SBRT series .", "label": "", "metadata": {}, "score": "60.73393"}
{"text": "View Article .Sharma NK , Li T , Chen DY , Pollack A , Horwitz EM , Buyyounouski MK : Intensity - modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer .", "label": "", "metadata": {}, "score": "60.782604"}
{"text": "4 , pp .687 - 691 , 1986 .View at Google Scholar \u00b7 View at Scopus . F. Leborgne , J. Fowler , J. H. Leborgne , and J. Mezzera , \" Later outcomes and alpha / beta estimate from hypofractionated conformal three - dimensional radiotherapy versus standard fractionation for localized prostate cancer , \" International Journal of Radiation Oncology , Biology , Physics , vol .", "label": "", "metadata": {}, "score": "60.794422"}
{"text": "69 , no .4 , pp .1084 - 1089 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Dearnaley , I. Syndikus , G. Sumo et al . , \" Conventional versus hypofractionated high - dose intensity - modulated radiotherapy for prostate cancer : preliminary safety results from the CHHiP randomised controlled trial , \" The Lancet Oncology , vol .", "label": "", "metadata": {}, "score": "60.814293"}
{"text": "Increased number of resting and terminally differentiated NK cells correlated with several dosimetric parameters , and GI and GU toxicity .Table 5 summarizes the Pearson 's correlations between the immune and dosimetric variables on day 14 of RT , and 15 - 20 days post - radiotherapy .", "label": "", "metadata": {}, "score": "60.95534"}
{"text": "Fuller DB , Naitoh J , Lee C , Hardy S , Jin H : Virtual HDR CyberKnife treatment for localized prostatic carcinoma : dosimetry comparison with HDR brachytherapy and preliminary clinical observations .", "label": "", "metadata": {}, "score": "60.98375"}
{"text": "Thirty - six intermediate - risk patients and 105 high - risk patients were included .Androgen - deprivation therapy was performed in 124 patients ( 88 % ) for a median of 11 months ( range : 2 - 88 months ) .", "label": "", "metadata": {}, "score": "60.994156"}
{"text": "[36 ] .The risk of late GU reactions depended on the percentage of urinary bladder volume receiving 40 Gy , the 3DCRT technique used , and the previous urological surgery [ 21 , 29 ] .", "label": "", "metadata": {}, "score": "61.113594"}
{"text": "The acute exposure to low- and high - dose irradiation in mouse models changes the quantitative and functional parameters of immune cells , due to different sensitivity of splenocyte subsets to radiation doses [ 9 ] .", "label": "", "metadata": {}, "score": "61.14383"}
{"text": "There were 303 assessable patients entered between 2002 and 2006 .There were 152 patients assigned to receive standard fractionation and 151 patients assigned to receive hypofractionation .", "label": "", "metadata": {}, "score": "61.209328"}
{"text": "The 3DCRT technique itself , patient age , T stage of TNM classification , surgical intervention , and some dose - volume parameters emerged as important factors in the probability of developing acute and late GI / GU toxicity .", "label": "", "metadata": {}, "score": "61.220264"}
{"text": "PubMed View Article .Prada PJ , Jimenez I , Gonz\u00e1lez - Su\u00e1rez H , Fern\u00e1ndez J , Cuervo - Arango C , Mendez L : High - dose - rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer : treatment description and preliminary results .", "label": "", "metadata": {}, "score": "61.221878"}
{"text": "These outcomes were proved in our study , as well .The development of acute 3DCRT- induced GI and/or GU damage was generally mild in both groups ; and none of the patients had an interruption of radiotherapy due to toxicity side effects .", "label": "", "metadata": {}, "score": "61.233124"}
{"text": "RTOG - EORTC toxicity and the IPSS questionnaires were sent to the patients at the following time points : baseline , at 1 , 2 , 3 , 6 , 12 months after treatment , and twice yearly thereafter .", "label": "", "metadata": {}, "score": "61.28582"}
{"text": "PubMed View Article .Int J Radiat Oncol Biol Phys 2009 , 73 : 1023 - 1032 .PubMed View Article .Kalakota K , Rakhno E , Pelizzari CA , Jani AB , Liauw SL : Late rectal toxicity after prostate brachytherapy : influence of supplemental external beam radiation on dose - volume histogram analysis .", "label": "", "metadata": {}, "score": "61.30759"}
{"text": "Table 5 .Comparative Rates of Acute Maximum RTOG Grade GI Toxicity for Prostate IMRT with no Endorectal Balloon , an Air - filled Endorectal Balloon , and a Water - filled Endorectal Balloon .", "label": "", "metadata": {}, "score": "61.331665"}
{"text": "PubMed View Article .Dearnaley DP , Sydes MR , Graham JD : Escalated - dose versus standard - dose conformal radiotherapy in prostate cancer : first results from the MRC RT01 randomised controlled trial .", "label": "", "metadata": {}, "score": "61.369354"}
{"text": "We assume that the limiting factor in high - volume irradiation is not the dosimetric parameters , but the overall patient tolerance .In addition , the WP technique was undergone by patients with advanced stages of disease , lower overall health status , and suppressed immune functions .", "label": "", "metadata": {}, "score": "61.37889"}
{"text": "6 , article 358 , 1991 .View at Google Scholar \u00b7 View at Scopus .J. E. Livsey , R. A. Cowan , J. P. Wylie et al . , \" Hypofractionated conformal radiotherapy in carcinoma of the prostate : five - year outcome analysis , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "61.37998"}
{"text": "6 , pp .1133 - 1139 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. A. Kuban , S. L. Tucker , L. Dong et al . , \" Long - term results of the M. D. Anderson randomized dose - escalation trial for prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "61.38805"}
{"text": "As though their suggestion was that the .ratio for prostate cancer might be low ( 1.5 ) comparable to that of late sequelae .Recent analysis of clinical data by Fowler et al .", "label": "", "metadata": {}, "score": "61.42572"}
{"text": "Furthermore , they also reported an equivalent overall survival rate of 85 % in both hypofractionated and conventional regimen .Furthermore , another prospective phase III randomized clinical trial by Arcangeli et al .", "label": "", "metadata": {}, "score": "61.46245"}
{"text": "[ 8 ] , Hoskin et al .[ 3 ] and Yoshioka et al .[ 2 ] likewise failed to verify Gleason score and pre - treatment PSA or clinical stage as significant predictors of risk of biochemical failure .", "label": "", "metadata": {}, "score": "61.697914"}
{"text": "The proportion of patients suffering pretreatment GU , as well as GI pathologies , was comparable in the groups undergoing either the WP or PO 3DCRT therapy .", "label": "", "metadata": {}, "score": "61.719536"}
{"text": "On the other hand , there were no significant differences in acute GU and GI toxicity between the two groups .In particular , acute GU toxicity was well observed in both the monotherapy group and the boost group .", "label": "", "metadata": {}, "score": "61.771698"}
{"text": "Morbidity was measured with the LENT - SOMA questionnaires .Gastrointestinal and genitourinary toxicity did not differ significantly between fractionation schedules .Investigators found that the conventional fractionation independently predicted for worse biochemical failure and genitourinary symptoms at 4 years .", "label": "", "metadata": {}, "score": "61.80883"}
{"text": "The estimated overall survival and metastasis - free survival were respectively 98 % , 98 % and 99 % , 98 % at 36 and 60 months .", "label": "", "metadata": {}, "score": "61.871975"}
{"text": "The authors used image - guided IMRT to treat men with localized prostate cancer using 2.5 Gy fractions to 70 Gy .The observed gastrointestinal and genitourinary morbidity in this trial was acceptable .", "label": "", "metadata": {}, "score": "61.87686"}
{"text": "PubMed View Article .Pollack A , Zagars GK , Starkschall G : Prostate cancer radiation dose response : results of the M. D. Anderson phase III randomized trial .", "label": "", "metadata": {}, "score": "61.9668"}
{"text": "Our treatment modality has also limitations .Intraprostatic calcifications may impair TRUS imaging quality thereby limiting real - time US - based treatment planning and dose conformality .", "label": "", "metadata": {}, "score": "61.97139"}
{"text": "Another series from the United Kingdom has been reported by Livsey et al .[ 18 ] at the Christie Hospital .The series included more than 700 men treated with hypofractionated radiotherapy over a period from 1995 to 1998 using 3.13 Gy fractions to 50 Gy .", "label": "", "metadata": {}, "score": "61.978134"}
{"text": "PubMed View Article .Zelefsky MJ , Nedelka MA , Arican ZL , Yamada Y , Cohen GN , Shippy AM , Park JJ , Zaider M : Combined brachytherapy with external beam radiotherapy for localized prostate cancer : reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity - modulated radiation therapy .", "label": "", "metadata": {}, "score": "62.023098"}
{"text": "PubMed View Article .Namiki S , Ishidoya S , Ito A , Tochigi T , Numata I , Narazaki K , Yamada S , Takai Y , Arai Y : Five - year follow - up of health - related quality of life after intensity - modulated radiation therapy for prostate cancer .", "label": "", "metadata": {}, "score": "62.047207"}
{"text": "Tabi et al . reported a prevalent loss of naive and early memory cells vs. more differentiated T cells in peripheral blood of patients during RT to the pelvis [ 11 ] .", "label": "", "metadata": {}, "score": "62.051517"}
{"text": "The t -test was used to compare continuous variables , and the chi - square test for categorical variables .The chi - square test was also used to test the difference in the incidence of adverse events between the monotherapy group and the boost group at each visit .", "label": "", "metadata": {}, "score": "62.08997"}
{"text": "PubMed View Article .Liao YP , Wang CC , Schaue D , Iwamoto KS , McBride WH : Local irradiation of murine melanoma affects the development of tumour - specific immunity .", "label": "", "metadata": {}, "score": "62.1124"}
{"text": "Kaplan - Meier actuarial analysis of all 351 patients for : ( a ) Biochemical control , overall survival and metastasis - free survival and ( b ) Biochemical control by risk group .", "label": "", "metadata": {}, "score": "62.161133"}
{"text": "BED was calculated to evaluate an independent factor to predict GU and GI toxicity , and an \u03b1 / \u03b2 ratio of 2 was used [ 1 ] .", "label": "", "metadata": {}, "score": "62.16336"}
{"text": "PubMed View Article .Jereczek - Fossa BA , Jassem J , Badzio A : Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer .", "label": "", "metadata": {}, "score": "62.1819"}
{"text": "Clinical assessment .Patients were monitored weekly during treatment and seen within 1 - 3 months after RT completion .At each visit , a history was obtained with emphasis on treatment - related morbidity .", "label": "", "metadata": {}, "score": "62.19135"}
{"text": "The mean IPSS increased to 13/35 at 12 months after treatment , resolved to 10/35 at 24 months ( Figure 2 ) .This reached a peak at 12 months in 20 % of patients resolving to 10 % at 24 months .", "label": "", "metadata": {}, "score": "62.216015"}
{"text": "Details on treatment planning and applied constraints can be found in an earlier report [ 7 ] .PSA measurement , toxicity , and QoL .", "label": "", "metadata": {}, "score": "62.249207"}
{"text": "PubMed View Article .Zilli T , Taussky D , Donath D , Le HP , Larouche RX , B\u00e9liveau - Nadeau D , Hervieux Y , Delouya G : Urethra - sparing , intraoperative , real - time planned , permanent - seed prostate brachytherapy : toxicity analysis .", "label": "", "metadata": {}, "score": "62.343185"}
{"text": "This paper analyses in detail the clinical outcome of our two - implant approach during the four - year time frame of 2004 - 2008 when we treated consecutively a cohort of 351 patients .", "label": "", "metadata": {}, "score": "62.351837"}
{"text": "43 , pp .370 - 381 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. J. Katz , M. Santoro , F. DiBlasio , et al . , \" Stereotactic body radiation therapy for low , intermediate , and high - risk prostate cancer : disease control and quality of life , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "62.365753"}
{"text": "PubMed View Article .Peddada AV , Jennings SB , Faricy PO , Walsh RA , White GA , Monroe AT : Low morbidity following high dose rate brachytherapy in the setting of prior transurethral prostate resection .", "label": "", "metadata": {}, "score": "62.475212"}
{"text": "1043 - 1048 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. R. King , J. D. Brooks , H. Gill , and J. C. Presti Jr. , \" Long - term outcomes from a prospective trial of stereotactic body radiotherapy for low - risk prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "62.544277"}
{"text": "PubMed View Article .Takeda K , Ogawa Y , Ariga H , Koto M , Sakayauchi T , Fujimoto K , Narazaki K , Mitsuya M , Takai Y , Yamada S : Clinical correlations between treatment with anticoagulants / antiaggregants and late rectal toxicity after radiotherapy for prostate cancer .", "label": "", "metadata": {}, "score": "62.55176"}
{"text": "78 - 81 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. A. Ritter , J. D. Forman , P. A. Kupelian , et al . , \" A phase I / II trial of increasingly hypofractionated radiation therapy for prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "62.579273"}
{"text": "56 , no .4 , pp .1093 - 1104 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. J. Brenner , \" The linear - quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction , \" Seminars in Radiation Oncology , vol .", "label": "", "metadata": {}, "score": "62.583458"}
{"text": "All GU and the majority of GI symptoms had resolved 2 months after treatment .Although no grade 3 - 4 side effects were observed , the investigators noted an increase of grade 1 - 2 early side effects as compared to a conventional regimen .", "label": "", "metadata": {}, "score": "62.590813"}
{"text": "[ 24 , 29 ] reported preliminary results of a multi - center phase I / II clinical trial that explored the increasingly hypofractionated radiation therapy for localized prostate cancer .", "label": "", "metadata": {}, "score": "62.618652"}
{"text": "PubMed View Article .Tanaka N , Asakawa I , Kondo H , Tanaka M , Fujimoto K , Hasegawa M , Konishi N , Hirao Y : Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer : our first series of 100 patients .", "label": "", "metadata": {}, "score": "62.73042"}
{"text": "PubMed View Article .Barkati M , Williams SG , Foroudi F : High - dose - rate brachytherapy as a monotherapy for favorable - risk prostate cancer : a phase II trial .", "label": "", "metadata": {}, "score": "62.733326"}
{"text": "11 , pp .715 - 721 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Norkus , A. Miller , A. Plieskiene , E. Janulionis , and K. P. Valuckas , \" A randomized trial comparing hypofractionated and conventionally fractionated three - dimensional conformal external - beam radiotherapy for localized prostate adenocarcinoma : a report on the first - year biochemical response , \" Medicina , vol .", "label": "", "metadata": {}, "score": "62.832138"}
{"text": "Routine implementation of IMRT with tight PTV margins and IGRT are likely to have contributed to reduce the treatment - related toxicities .A recently completed RTOG 0415 Phase III trial assigned randomized patients to either the hypofractionation treatment strategy from the report by Kupelian et al .", "label": "", "metadata": {}, "score": "62.832848"}
{"text": "PubMed View Article .Liu M , Pickles T , Berthelet E , Agranovich A , Kwan W , Tyldesley S , McKenzie M , Keyes M , Morris J , Pai H : Urinary incontinence in prostate cancer patients treated with external beam radiotherapy .", "label": "", "metadata": {}, "score": "62.92682"}
{"text": "The mean pretreatment IPSS was 8 \u00b1 7 ( 0 - 34 ) , and the mean subjective IPSS score was 2 \u00b1 1 ( 0 - 5 ) .", "label": "", "metadata": {}, "score": "62.965546"}
{"text": "G. W. Jones , C. Mettlin , G. P. Murphy et al . , \" Patterns of care for carcinoma of the prostate gland : results of a national survey of 1984 and 1990 , \" Journal of the American College of Surgeons , vol .", "label": "", "metadata": {}, "score": "63.050484"}
{"text": "PubMed View Article .Bordon E , Henriquez - Hernandez LA , Lara PC , Pinar B , Rodriguez - Gallego C , Lloret M : Role of CD4 and CD8 T - lymphocytes , B - lymphocytes and Natural Killer cells in the prediction of radiation - induced late toxicity in cervical cancer patients .", "label": "", "metadata": {}, "score": "63.06794"}
{"text": "PubMed View Article .Zelefsky MJ , Yamada Y , Cohen GN , Shippy A , Chan H , Fridman D , Zaider M : Five - year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer .", "label": "", "metadata": {}, "score": "63.243767"}
{"text": "Published clinical data will be classified into four categories .The first category includes retrospective clinical trials that have been analyzed post hoc to evaluate .", "label": "", "metadata": {}, "score": "63.31118"}
{"text": "5 , pp .473 - 477 , 2010 .View at Google Scholar \u00b7 View at Scopus .J. L. Friedland , D. E. Freeman , M. E. Masterson - McGary , and D. M. Spellberg , \" Stereotactic body radiotherapy : an emerging treatment approach for localized prostate cancer , \" Technology in Cancer Research and Treatment , vol . 8 , no .", "label": "", "metadata": {}, "score": "63.32652"}
{"text": "Patients with a follow - up period within 1 year were also not registered in this analysis .A total of 105 patients with high - risk localized prostate cancer and 36 patients with intermediate - risk localized prostate cancer received IMRT up to a prescribed dose of 76 Gy or 80 Gy and were investigated .", "label": "", "metadata": {}, "score": "63.363136"}
{"text": "View Article .Int J Radiat Oncol Biol Phys 2007 , 69 ( 4 ) : 1100 - 1109 .PubMed View Article .Karlsdottir A , Johannessen DC , Muren LP , Wentzel - Larsen T , Dahl O : Acute morbidity related to treatment volume during 3D - conformal radiation therapy for prostate cancer .", "label": "", "metadata": {}, "score": "63.366444"}
{"text": "[17 ] reported a British dose escalation study for prostate cancer using hypofractionated IMRT regimen using a higher dose per fraction .Patients received 57 - 60 Gy to the prostate in 19 - 20 fractions using five - field IMRT .", "label": "", "metadata": {}, "score": "63.374157"}
{"text": "Results .PSA at diagnosis , biopsy Gleason score , and clinical stage in the monotherapy group were significantly higher than those in the boost group , while patients ' age in the monotherapy group was significantly younger than that in the boost group .", "label": "", "metadata": {}, "score": "63.385612"}
{"text": "Zelefsky MJ , Kuban DA , Levy LB : Multi - institutional analysis of long - term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation .", "label": "", "metadata": {}, "score": "63.42813"}
{"text": "PubMed View Article .Bogdandi EN , Balogh A , Felgyinszki N , Szatmari T , Persa E , Hildebrandt G , Safrany G , Lumniczky K : Effects of low - dose radiation on the immune system of mice after total - body irradiation .", "label": "", "metadata": {}, "score": "63.44877"}
{"text": "Keywords .Clinical outcome Low- and intermediate - risk Radiotherapy Prostate cancer Stereotactic body radiation .Background .Although external beam radiotherapy ( EBRT ) is a highly effective treatment for prostate cancer ( PC ) , the long course of 7 - 9 weeks can have a negative impact on the patients ' quality of life ( QoL ) and hospital resources .", "label": "", "metadata": {}, "score": "63.462265"}
{"text": "PubMed View Article .Ghadjar P , Keller T , Rentsch CA : Toxicity and early treatment outcomes in low- and intermediate - risk prostate cancer managed by high - dose - rate brachytherapy as a monotherapy .", "label": "", "metadata": {}, "score": "63.480057"}
{"text": "Dose specification was given as the mean dose on the PTV surface .The prescribed reference dose was 9.5 Gy delivered four times to a total dose of 38.0 Gy using two implants .", "label": "", "metadata": {}, "score": "63.556587"}
{"text": "Among these patients , 44 ( 35 % ) received only neoadjuvant ADT , and the other 80 ( 65 % ) were treated with neoadjuvant ADT , concurrent and adjuvant ADT .", "label": "", "metadata": {}, "score": "63.57086"}
{"text": "However , the authors relied again on a short - term endpoint ( biochemical control at 3 years ) .From the original population of 192 patients , the authors managed to analyze the results in 121 men .", "label": "", "metadata": {}, "score": "63.658253"}
{"text": "PubMed View Article .Zelefsky MJ , Chan H , Hunt M , Yamada Y , Shippy AM , Amols H : Long - term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer .", "label": "", "metadata": {}, "score": "63.677757"}
{"text": "There are of course some limitations in our study .It encompassed 351 patients who were not treated within a multi - institutional framework but at a single tertiary - care center .", "label": "", "metadata": {}, "score": "63.68255"}
{"text": "The median duration between the initiation of ADT and the start of IMRT was 8 months ( range : 1 - 36 months ) .After treatment follow - up evaluation .", "label": "", "metadata": {}, "score": "63.744183"}
{"text": "The incidence rates of GU and GI toxicity were significantly different between patients in the monotherapy and the boost groups .The boost group showed a higher incidence rate , especially of GI toxicity .", "label": "", "metadata": {}, "score": "63.76079"}
{"text": "However , there were no statistically significant changes in AUA scores or EPIC Urinary scores .In addition to the progressively larger dose per fraction used in the previously mentioned clinical studies , researchers at University of Texas at Southwestern Medical Center at Dallas ( UTSW ) conducted an animal experiment using higher doses per fraction .", "label": "", "metadata": {}, "score": "63.84116"}
{"text": "Dale W , Campbell T , Ignacio L , Song P , Kopnick M , Mamo C , Ray P , Vijayakumar S : Self - assessed health - related quality of life in men being treated for prostate cancer with radiotherapy : instrument validation and its relation to patient - assessed bother of symptoms .", "label": "", "metadata": {}, "score": "63.944675"}
{"text": "PubMed View Article .Demanes DJ , Martinez AA , Ghilezan M : High - dose - rate monotherapy : safe and effective brachytherapy for patients with localized prostate cancer .", "label": "", "metadata": {}, "score": "63.95732"}
{"text": "PubMed View Article .Int J Radiat Oncol Biol Phys 2011 , 80 ( 4 ) : 1056 - 1063 .PubMed View Article .Lips IM , Dehnad H , van Gils CH , Kruger AEB , van der Heide UA , van Vulpen M : High - dose intensity - modulated radiotherapy for prostate cancer using daily fiducial marker - based position verification : acute and late toxicity in 331 patients .", "label": "", "metadata": {}, "score": "64.15077"}
{"text": "For every treatment fraction , the patients were initially prepared using laser marks on their skin , and they were then repositioned using the Varian On - Board Imager based on the positions of the three intra - prostatic fiducial markers , and the precision - of - position verification was within 1 mm .", "label": "", "metadata": {}, "score": "64.15205"}
{"text": "The peculiarity that the .ratio of prostate cancer is low implies that , theoretically , a hypofractionated radiation treatment schedule would increase the therapeutic gain of radiotherapy .", "label": "", "metadata": {}, "score": "64.2097"}
{"text": "2 ng / mL definition .These results compare favourably to those achieved in patients contemporaneously treated with conventional fractionation at the Cleveland Clinic ( 78 Gy at 2 Gy / fraction ) .", "label": "", "metadata": {}, "score": "64.24092"}
{"text": "4 , pp . 1033 - 1039 , 2004 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Barnes , H. Pass , and A. DeLuca , \" Response of the mediastinal and thoracic viscera of the dog to intraoperative radiation therapy ( IORT ) , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "64.272194"}
{"text": "Doses lower than 44 Gy and higher than 54 Gy , did not exhibit statistically significant correlations with leukocyte number .In the scope of PBM irradiation , we found a positive correlation between low doses ( 1 - 43Gy ) and NK cell numbers during RT ( Table 4 ) .", "label": "", "metadata": {}, "score": "64.274254"}
{"text": "The external contour of the PBM was delineated on the planning CT using bone windows .To find the association of local radiation doses and changes in the number of leukocytes among patients with different body sizes , the percentage of BM irradiated volume at different doses was used as a first approximation .", "label": "", "metadata": {}, "score": "64.28197"}
{"text": "Pooled data of patients in each treatment group , at all time points tested , are presented as mean values , where standard deviation does not exceed 10 % .", "label": "", "metadata": {}, "score": "64.33477"}
{"text": "in press .Fuller DB , Naitoh J , Lee C , Hardy S , Jin H : Virtual HDR CyberKnife treatment for localized prostatic carcinoma : dosimetry comparison with HDR brachytherapy and preliminary clinical observations .", "label": "", "metadata": {}, "score": "64.37363"}
{"text": "Postdosimetric evaluation .Therapeutic planning and post - implant dosimetric evaluation were performed using the planning system Interplant Version 3.3 ( CMS , Inc. , St. Louis , USA ) from July 2004 to October 2008 , and Variseed 8.0 ( Varian Medical Systems , Palo Alto , CA , USA ) thereafter .", "label": "", "metadata": {}, "score": "64.39453"}
{"text": "5 , pp .756 - 759 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. J. Zelefsky , X. Pei , J. F. Chou et al . , \" Dose escalation for prostate cancer radiotherapy : predictors of long - term biochemical tumor control and distant metastases - free survival outcomes , \" European Urology , vol .", "label": "", "metadata": {}, "score": "64.49331"}
{"text": "PubMed View Article .Radiother Oncol 2004 , 73 : 21 - 32 .PubMed View Article .Skwarchuk MW , Jackson A , Zelefsky MJ , Venkatraman ES , Cowen DM , Levegrun S , Burman CM , Fuks Z , Leibel SA , Ling CC : Late rectal toxicity after conformal radiotherapy of prostate cancer ( I ) : multivariate analysis and dose - response .", "label": "", "metadata": {}, "score": "64.53949"}
{"text": "The mean dose to this visible dominant tumor area defined as gross target volume ( GTV ) was 47.8 Gy ( 40.3 - 53.8 Gy ) which is 120 - 150 % higher than the PD .", "label": "", "metadata": {}, "score": "64.55761"}
{"text": "127 - 132 , 1991 .View at Google Scholar \u00b7 View at Scopus .W. Duncan , P. Warde , C. N. Catton et al . , \" Carcinoma of the prostate : results of radical radiotherapy ( 1970 - 1985 ) , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "64.565186"}
{"text": "Further investigation is needed to optimize integration between dose - escalated radiotherapy and adequate ADT .Additionally , longer follow - up is essential to evaluate the long - term treatment outcomes .", "label": "", "metadata": {}, "score": "64.6592"}
{"text": "15 , no . 1 , pp . 1 - 6 , 2009 .View at Google Scholar \u00b7 View at Scopus .M. Carlone , D. Wilkins , B. Nyiri , and P. Raaphorst , \" Comparison of \u03b1 / \u03b2 estimates from homogeneous ( individual ) and heterogeneous ( population ) tumor control models for early stage prostate cancer , \" Medical Physics , vol .", "label": "", "metadata": {}, "score": "64.70263"}
{"text": "PubMed View Article .Zelefsky MJ , Leibel SA , Gaudin PB , Kutcher GJ , Fleshner NE , Venkatramen ES , Reuter VE , Fair WR , Ling CC , Fuks Z : Dose escalation with three - dimensional conformal radiation therapy affects the outcome in prostate cancer .", "label": "", "metadata": {}, "score": "64.707954"}
{"text": "The findings of the present analysis confirm monotherapeutic HDR BRT to be a safe and effective modality for clinically localised prostate cancer .Three - dimensional TRUS - based intraoperative real - time treatment planning provided accurate dosimetry with precise radiation delivery ensuring an acceptable side effect profile .", "label": "", "metadata": {}, "score": "64.77126"}
{"text": "Int J Radiat Oncol Biol Phys 2004 , 58 : 11 - 18 .PubMed View Article .Roach M 3rd , Hanks G , Thames H Jr , Schellhammer P , Shipley WU , Sokol GH , Sandler H : Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer : recommendations of the RTOG - ASTRO Phoenix Consensus Conference .", "label": "", "metadata": {}, "score": "64.78679"}
{"text": "From March 2004 to January 2008 , 351 patients received two implants , separated by two weeks , each of two fractions of 9.5 Gy .", "label": "", "metadata": {}, "score": "64.81372"}
{"text": "371 - 378 , 1987 .View at Google Scholar \u00b7 View at Scopus .G. Bolzicco , M. S. Favretto , E. Scremin , C. Tambone , A. Tasca , and R. Guglielmi , \" Image - guided stereotactic body radiation therapy for clinically localized prostate cancer : preliminary clinical results , \" Technology in Cancer Research and Treatment , vol .", "label": "", "metadata": {}, "score": "64.84518"}
{"text": "The use of high - dose - rate brachytherapy ( HDR - BT ) is proven to be safe and effective and this technique is increasingly used either as a boost after EBRT or as monotherapy [ 4 , 5 ] .", "label": "", "metadata": {}, "score": "64.927345"}
{"text": "PubMed View Article .Ohashi T , Yorozu A , Toya K , Saito S , Momma T , Nagata H , Kosugi M : Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry .", "label": "", "metadata": {}, "score": "65.023834"}
{"text": "78 - 81 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. A. Ritter , J. D. Forman , and D. G. Petereit , \" Dose - per - fraction escalation for localized prostate cancer : a multi - institutional phase I / II Trial , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "65.053894"}
{"text": "Discussion .Our results show that high - dose image - guided IMRT can be safely performed and is well tolerated .This study also demonstrated relatively few biochemical failures after image - guided IMRT in patients with intermediate- and high - risk localized prostate cancer as a medium - term period assessment [ Table 4 ] .", "label": "", "metadata": {}, "score": "65.05904"}
{"text": "PubMed View Article .Zelefsky MJ , Leibel SA , Gaudin PB : Dose escalation with three - dimensional conformal radiation therapy affects the outcome in prostate cancer .", "label": "", "metadata": {}, "score": "65.08945"}
{"text": "Kupelian et al .[20 ] at the Cleveland Clinic were among the first that combined improvements in radiotherapy technology with the low .ratio hypothesis in order to examine a hypofractionated regimen in a controlled phase I / II clinical trial .", "label": "", "metadata": {}, "score": "65.17357"}
{"text": "Methods .Patients and planning .Between June 2008 and November 2011 , 50 hormone - na\u00efve patients with biopsy - proven low- to intermediate- risk PC underwent SBRT treatment of PC , using the Cyberknife \u00ae , in four daily fractions of 9.5 Gy to a total dose of 38 Gy .", "label": "", "metadata": {}, "score": "65.173676"}
{"text": "The rate of biochemical control was 97 % at 14 months by the Phoenix definition and 76 % at 3 years by the older ASTRO consensus definition .", "label": "", "metadata": {}, "score": "65.19569"}
{"text": "ratio of 3 for late normal tissue effects .The treatments were delivered with 3 Gy per fraction , 5 days per week for 4 consecutive weeks to a minimum dose of 60 Gy to the CTV ( entire prostate and the base of seminal vesicles ) .", "label": "", "metadata": {}, "score": "65.27866"}
{"text": "Partin AW , Kattan MW , Subong EN , Walsh PC , Wojno KJ , Oesterling JE , Scardino PT , Pearson JD : Combination of prostate - specific antigen , clinical stage , and Gleason score to predict pathological stage of localized prostate cancer .", "label": "", "metadata": {}, "score": "65.34462"}
{"text": "Alicikus ZA , Yamada Y , Zhang Z , Pei X , Hunt M , Kollmeier M , Cox B , Zelefsky MJ : Ten - year outcomes of high - dose , intensity - modulated radiotherapy for localized prostate cancer .", "label": "", "metadata": {}, "score": "65.368484"}
{"text": "PubMed .Peeters ST , Heemsbergen WD , van Putten WL , Slot A , Tabak H , Mens JW , Lebesque JV , Koper PC : Acute and late complications after radiotherapy for prostate cancer : results of a multicenter randomized trial comparing 68 Gy to 78 Gy .", "label": "", "metadata": {}, "score": "65.385925"}
{"text": "PubMed View Article .Madsen BL , Hsi RA , Pham HT , Fowler JF , Esagui L , Corman J : Stereotactic hypofractionated accurate radiotherapy of the prostate ( SHARP ) , 33.5 Gy in five fractions for localized disease : first clinical trial results .", "label": "", "metadata": {}, "score": "65.41573"}
{"text": "The institutional research ethics board approved this study .Radiotherapy .The detailed techniques for IMRT treatment planning and delivery have been previously reported [ 5 ] .", "label": "", "metadata": {}, "score": "65.456436"}
{"text": "The small number of biochemical failures could be a function of the short follow - up .Third , we unfortunately did not estimate sexual function before and after treatment in this analysis , whereas several authors have reported a relationship between ADT use and the development of erectile dysfunction [ 1 , 26 , 27 ] .", "label": "", "metadata": {}, "score": "65.48105"}
{"text": "The Foley catheter was delineated as the urethra .The CT and MRI images were matched on the markers and the Foley catheter .All patients followed a low fiber dietary protocol to minimize intestinal activity .", "label": "", "metadata": {}, "score": "65.4977"}
{"text": "ratio is consistent with a greater capacity for repair between fractions , with an accompanying greater relative sparing with small fraction sizes , than for tumors with their typically higher . ratios .", "label": "", "metadata": {}, "score": "65.50017"}
{"text": "Vancouver .Arcangeli S , Strigari L , Soete G , De Meerleer G , Gomellini S , Fonteyne V , et al .CLINICAL AND DOSIMETRIC PREDICTORS OF ACUTE TOXICITY AFTER A 4-WEEK HYPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY REGIMEN FOR PROSTATE CANCER : RESULTS FROM A MULTICENTRIC PROSPECTIVE TRIAL .", "label": "", "metadata": {}, "score": "65.52242"}
{"text": "An international field study of the EORTC QLQ - PR25 : a questionnaire for assessing the health - related quality of life of patients with prostate cancer .", "label": "", "metadata": {}, "score": "65.546936"}
{"text": "View Article .Int J Radiat Oncol Biol Phys 2010 , 78 : 26 - 34 .PubMed View Article .Schultheiss TE , Lee WR , Hunt MA , Hanlon AL , Peter RS , Hanks GE : Late GI and GU complications in the treatment of prostate cancer .", "label": "", "metadata": {}, "score": "65.55363"}
{"text": "Results from several clinical studies of hypofractionated radiotherapy , especially with IMRT , have found that late gastrointestinal and genitourinary toxicity is well tolerated .Another potential benefit of hypofractionated radiotherapy is reduction in treatment cost and shortening of waiting lists in high - volume radiotherapy departments .", "label": "", "metadata": {}, "score": "65.575485"}
{"text": "PubMed View Article .Hurwitz MD , Kaur P , Nagaraja GM , Bausero MA , Manola J , Asea A : Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer .", "label": "", "metadata": {}, "score": "65.57899"}
{"text": "PubMed View Article .Peeters ST , Hoogeman MS , Heemsbergen WD , Hart AA , Koper PC , Lebesque JV : Rectal bleeding , fecal incontinence , and high stool frequency after conformal radiotherapy for prostate cancer : normal tissue complication probability modeling .", "label": "", "metadata": {}, "score": "65.58854"}
{"text": "In addition , a higher EBRT dose requires greater accuracy and precision .Thus , various position verification methods , including image - guided radiotherapy , have been developed , and their effectiveness has been reported [ 3 ] .", "label": "", "metadata": {}, "score": "65.658516"}
{"text": "The median duration of ADT in the 24 intermediate - risk and 100 high - risk patients was 5 months ( range : 4 - 32 months ) and 12 months ( range : 2 - 88 months ) , respectively .", "label": "", "metadata": {}, "score": "65.70299"}
{"text": "Patient selection and characteristics .Since 2002 , we have treated more than 900 patients with HDR monotherapy for clinically localised prostate cancer .During this period , three different protocols were implemented reflecting an evolution aiming to improve clinical workflow and patient comfort .", "label": "", "metadata": {}, "score": "65.74491"}
{"text": "5 , pp .545 - 554 , 1995 .View at Google Scholar \u00b7 View at Scopus .C. D. Collins , R. W. Lloyd - Davies , and A. V. Swan , \" Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique , \" Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "65.799034"}
{"text": "In most cases the prostate cancer is organ - confined at the time of initial diagnosis [ 2 ] .Regarding the specific option of external beam radiotherapy , the current widely accepted standard regimen for organ - confined prostate cancer in the USA involves approximately eight weeks of fractionated treatments with a daily dose of 1.8 - 2.0 Gy to a total dose in the range of 70 - 80 Gy .", "label": "", "metadata": {}, "score": "65.86138"}
{"text": "PubMed View Article .Pinkawa M , Holy R , Piroth MD , Fischedick K , Schaar S , Szekely - Orban D , Eble MJ : Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study .", "label": "", "metadata": {}, "score": "65.91429"}
{"text": "View at Google Scholar . Y. Lotan , J. Stanfield , L. C. Cho et al . , \" Efficacy of high dose per fraction radiation for implanted human prostate cancer in a nude mouse model , \" Journal of Urology , vol .", "label": "", "metadata": {}, "score": "65.92105"}
{"text": "Moreover , according to D'Amico et al . and Bolla et al . , the radiotherapy survival benefit may be improved by adding ADT for high- and intermediate - risk localized prostate cancer [ 17 , 18 ] .", "label": "", "metadata": {}, "score": "65.9324"}
{"text": "518 - 526 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Pollack , G. Walker , and M. Buyyounouski , \" Five year results of a randomized external beam radiotherapy hypofractionation trial for prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "66.055954"}
{"text": "PubMed View Article .Tanaka N , Fujimoto K , Hirao Y , Asakawa I , Hasegawa M , Konishi N : Variations in international prostate symptom scores , uroflowmetric parameters , and prostate volume after ( 125)I permanent brachytherapy for localized prostate cancer .", "label": "", "metadata": {}, "score": "66.14069"}
{"text": "Patel RR , Orton N , Tom\u00e9 WA , Chappell R , Ritter MA : Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer .", "label": "", "metadata": {}, "score": "66.2661"}
{"text": "Table 3 .Note : The results are presented as mean \u00b1 standard deviation .The results listed as NA were not estimated due to the limited number of variations in the tested parameter .", "label": "", "metadata": {}, "score": "66.28219"}
{"text": "Further followup and reports of the third level of dose escalation ( 79.2 Gy ) are awaited .Blogs .Abstract .Background .There is growing evidence that prostate cancer ( PC ) cells are more sensitive to high fraction dose in hypofractionation schemes .", "label": "", "metadata": {}, "score": "66.32579"}
{"text": "There were no significant differences in the R100 value between the monotherapy and the boost groups ( Table 2 ) .It can however easily be conceived that the total dose to the rectum must be higher in the boost group .", "label": "", "metadata": {}, "score": "66.36076"}
{"text": "SHIM , AUA , and EPIC scores were used to assess quality of life in 56 % of the patients who filled out the questionnaires .", "label": "", "metadata": {}, "score": "66.421326"}
{"text": "There were no significant differences in the baseline IPSS between the monotherapy group and the boost group .The mean follow - up period in the monotherapy group was significantly longer than that in the boost group ( Table 1 ) .", "label": "", "metadata": {}, "score": "66.42302"}
{"text": "[19 ] reported the preplanned interim safety analysis of randomized multicenter Conventional or Hypofractionated High - Dose Intensity - Modulated Radiotherapy for Prostate Cancer ( CH HiP ) trial .", "label": "", "metadata": {}, "score": "66.53816"}
{"text": "A future report will include mature biochemical control rates data .One hundred sixty - eight patients were randomized to receive three - dimensional conformal radiotherapy to the prostate and seminal vesicles .", "label": "", "metadata": {}, "score": "66.56981"}
{"text": "To date Jabbari published the only series using our HDR like 4\u00d79.5 Gy scheme .The relative higher grade 3 GU toxicity in our series compared to other SBRT series could be explained by patient selection ; we treated patients with more complaints and predisposing factors .", "label": "", "metadata": {}, "score": "66.71163"}
{"text": "Despite these apparent advantages , this technique also poses a dosimetric challenge , because the air introduces significant heterogeneity , Since almost three - quarters of prostate cancer foci are present in the peripheral zone [ 8 ] in close rectal proximity this has led to concern of potential target under - dosing .", "label": "", "metadata": {}, "score": "66.80063"}
{"text": "Since the early reports of hypofractionation , there has been a steady increase in reports of hypofractionated radiotherapy for prostate cancer .Some have decreased the number of fractions modestly , and others have reduced it to only five sessions [ 41 - 50 ] .", "label": "", "metadata": {}, "score": "66.82372"}
{"text": "PubMed View Article .Sohn M , Yan D , Liang J , Meldolesi E , Vargas C , Alber M : Incidence of late rectal bleeding in high - dose conformal radiotherapy of prostate cancer using equivalent uniform dose - based and dose - volume - based normal tissue complication probability models .", "label": "", "metadata": {}, "score": "66.825"}
{"text": "[47 ] first reported their institutional experience using hypofractionation to treat safely an initial 100 consecutive patients with localized prostate cancer .Subsequently , an expanded experience involving 770 patients was reported [ 48 ] .", "label": "", "metadata": {}, "score": "66.86087"}
{"text": "67 - 74 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. L. Zietman , K. Bae , J. D. Slater et al . , \" Randomized trial comparing conventional - dose with high - dose conformal radiation therapy in early - stage adenocarcinoma of the prostate : long - term results from Proton Radiation Oncology Group / American College Of Radiology 95 - 09 , \" Journal of Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "66.94514"}
{"text": "Background .Methods .The first 100 patients undergoing prostate and proximal seminal vesicle IG - IMRT with indexed - lumen 100 cc ERB H2O to 79.2 Gy in 1.8 Gy fractions at our institution from 12/2008- 12/2010 were assessed .", "label": "", "metadata": {}, "score": "66.96261"}
{"text": "J. D. Cox , D. J. Grignon , R. S. Kaplan , J. T. Parsons , and P. F. Schellhammer , \" Consensus statement : guidelines for PSA following radiation therapy , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "67.02275"}
{"text": "All patients were immobilized in the supine position with a vacuum bag system for their entire body .Since January 2004 , we have temporarily used a urethral catheter for identification of the urethra on radiotherapy - planning CT images and for contouring the urethra after image acquisition .", "label": "", "metadata": {}, "score": "67.05214"}
{"text": "PubMed View Article .Freeman DE , King CR : Stereotactic body radiotherapy for low - risk prostate cancer : five - year outcomes .Radiat Oncol 2011 , 6 : 3 .", "label": "", "metadata": {}, "score": "67.1131"}
{"text": "PubMed View Article .Freeman DE , King CR : Stereotactic body radiotherapy for low - risk prostate cancer : five - year outcomes .Radiat Oncol 2011 , 6 : 3 .", "label": "", "metadata": {}, "score": "67.1131"}
{"text": "Logistic regression models evaluated univariate association between toxicities and dosimetric parameters , and uni- and multivariate association between toxicities and pretreatment characteristics .Results .Mean age was 68 ( range 51 - 88 ) .", "label": "", "metadata": {}, "score": "67.19237"}
{"text": "Both late GI and GU toxicities positively associated with the volume of the irradiated organ at risk , rectum and urinary bladder , respectively .Furthermore , the late GI toxicity is associated with stage T of TNM classification of the disease , and is strongly influenced by acute GI toxicity .", "label": "", "metadata": {}, "score": "67.240654"}
{"text": "Unfortunately , dose escalation using a conventionally fractionated treatment schedule requires a lengthened treatment course that is less convenient for patients and more costly for government and private insurance carriers .", "label": "", "metadata": {}, "score": "67.270065"}
{"text": "However , Takeshima et al . have found that tumor - specific CTL , which were induced in the draining lymph nodes and tumor tissue of mice by RT , are fundamental to the inhibition of cancer growth [ 37 ] .", "label": "", "metadata": {}, "score": "67.3551"}
{"text": "PubMed View Article .Zelefsky MJ , Yamada Y , Fuks Z , Zhang Z , Hunt M , Cahlon O , Park J , Shippy A : Long - term results of conformal radiotherapy for prostate cancer : impact of dose escalation on biochemical tumor control and distant metastases - free survival outcomes .", "label": "", "metadata": {}, "score": "67.36409"}
{"text": "PubMed View Article .Chen CT , Valicenti RK , Lu J , Derose T , Dicker AP , Strup SE , Mulholland SG , Hirsch IH , McGinnis DE , Gomella LG : Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer ?", "label": "", "metadata": {}, "score": "67.37336"}
{"text": "PubMed View Article .Corner C , Rojas AM , Bryant L , Ostler P , Hoskin P : A phase II study of high - dose - rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer .", "label": "", "metadata": {}, "score": "67.377144"}
{"text": "This topic is controversial .Several authors reported that ADT administration increases late GI toxicity [ 20 , 22 ] .In contrast , other studies have indicated lower GI and GU toxicity rates when ADT was added to EBRT for localized prostate cancer [ 23 , 24 ] .", "label": "", "metadata": {}, "score": "67.62242"}
{"text": "PubMed View Article .Liang Y , Messer K , Rose BS , Lewis JH , Jiang SB , Yashar CM , Mundt AJ , Mell LK : Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer : principal component analysis on high dimensional data .", "label": "", "metadata": {}, "score": "67.64034"}
{"text": "PubMed View Article .Chen ME , Johnston DA , Tang K , Babaian RJ , Troncoso P : Detailed mapping of prostate carcinoma foci : biopsy strategy implications .", "label": "", "metadata": {}, "score": "67.73248"}
{"text": "PubMed View Article .Chen ME , Johnston DA , Tang K , Babaian RJ , Troncoso P : Detailed mapping of prostate carcinoma foci : biopsy strategy implications .", "label": "", "metadata": {}, "score": "67.73248"}
{"text": "Post Hoc Analysis of Retrospective Clinical Trials .The article concerned with the low .ratio hypothesis of prostate cancer was first published in 1999 by Brenner and Hall [ 14 ] .", "label": "", "metadata": {}, "score": "67.75184"}
{"text": "The 5-year actuarial PSA relapse - free survival , the 5-year distant metastasis - free survival , the 5-year cause - specific survival ( CSS ) , the 5-year overall survival ( OS ) outcomes and the acute and late toxicities were analyzed .", "label": "", "metadata": {}, "score": "67.88701"}
{"text": "Final decisions concerning hormonal treatment were made by the referring urologists .Patient and tumour characteristics are shown in Table 1 .Brachytherapy protocol .Transperineal implantation was performed under TRUS guidance using a continuous probe movement technique [ 19 ] .", "label": "", "metadata": {}, "score": "67.906784"}
{"text": "PubMed View Article .Jacob R , Hanlon AL , Horwitz EM , Movsas B , Uzzo RG , Pollack A : The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer .", "label": "", "metadata": {}, "score": "67.950424"}
{"text": "PubMed View Article .Martinez AA , Pataki I , Edmundson G , Sebastian E , Brabbins D , Gustafson G : Phase II prospective study of the use of conformal high - dose - rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer : a feasibility report .", "label": "", "metadata": {}, "score": "67.97386"}
{"text": "Irradiation technique , target volume and critical normal structure definition .Treatment planning and irradiation were performed with the patients in supine position ( using knee and ankle supports ) with an emptied rectum and \" comfortably full \" bladder filling .", "label": "", "metadata": {}, "score": "67.97864"}
{"text": "Minimal percentage of the dose received by 30 % of the rectum .RD30 : .Minimal dose ( Gy ) by 30 % of the rectum . R100 : .", "label": "", "metadata": {}, "score": "68.00067"}
{"text": "Battermann JJ , Boon TA , Moerland MA : Results of permanent prostate brachytherapy , 13 years of experience at a single institution .Radiother Oncol 2004 , 71 : 23 - 28 .", "label": "", "metadata": {}, "score": "68.02139"}
{"text": "In order to maintain the favorable rectal toxicity profile , stringent rectal planning constraints were applied .This study analyzes our preliminary institutional experience using this approach , reporting the rates of acute genitourinary ( GU ) and gastrointestinal ( GI ) toxicity and assessing for toxicity associations with dose - volume histogram ( DVH ) parameters as well as patient characteristics .", "label": "", "metadata": {}, "score": "68.04735"}
{"text": "\" Infield \" OARs , defined as 1 cm above and below CTV , were also created for each structure .When necessary , acceptable deviations were consistent with dose level 3 of RTOG 9406 and considered ' minor ' if within 5 % of institutional goals .", "label": "", "metadata": {}, "score": "68.085014"}
{"text": "Conclusion .Our study demonstrates the association of acute and late damage of the urinary bladder and rectum , with clinical and treatment related factors .", "label": "", "metadata": {}, "score": "68.130295"}
{"text": "PubMed View Article .Fowler JF , Welsh JS , Howard SP : Loss of biological effect in prolonged fraction delivery .Int J Radiat Oncol Biol Phys 2004 , 59 : 242 - 249 .", "label": "", "metadata": {}, "score": "68.14326"}
{"text": "11 - 18 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus Purpose : To investigate predictors for gastrointestinal ( GI ) and genitourinary ( GU ) acute toxicity after a short - course hypofractionated radiotherapy regimen for prostate cancer .", "label": "", "metadata": {}, "score": "68.15228"}
{"text": "PubMed View Article .Aluwini S , van Rooij P , Hoogeman M , Bangma C , Kirkels WJ , Incrocci L , Kolkman - Deurloo IK : CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate - stage prostate cancer : early experience , feasibility , and tolerance .", "label": "", "metadata": {}, "score": "68.17359"}
{"text": "203 - 210 , 1993 .View at Google Scholar \u00b7 View at Scopus .G. Read and R. C. S. Poiton , \" Retrospective study of radiotherapy in early carcinoma of the prostate , \" British Journal of Urology , vol .", "label": "", "metadata": {}, "score": "68.21271"}
{"text": "Methods and materials .We retrospectively analyzed the first 100 patients undergoing prostate / proximal seminal vesicle IG - IMRT to 79.2 Gy in 1.8 Gy fractions at our institution between 12/2008 - 12/2010 .", "label": "", "metadata": {}, "score": "68.2211"}
{"text": "View at Google Scholar . H. Lukka , C. Hayter , and P. A. Warde , \" Randomized trial comparing two fractionation schedules for patients with localized prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "68.26105"}
{"text": "Several limitations exist in this study .First , this study had no randomization ; therefore , it had an inherent potential for selection bias .", "label": "", "metadata": {}, "score": "68.34718"}
{"text": "PubMed View Article .Hoskin P , Rojas A , Lowe G : High - dose - rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence .", "label": "", "metadata": {}, "score": "68.358696"}
{"text": "5 , pp .1254 - 1259 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. D. Cox , D. J. Grignon , R. S. Kaplan , J. T. Parsons , and P. F. Schellhammer , \" Consensus statement : guidelines for PSA following radiation therapy , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "68.395035"}
{"text": "[ 7 ] , Bentzen and Ritter [ 6 ] showed remarkable agreement with the conclusion of Brenner and Hall 's 1999 conclusions .These estimates are consistent with the very slow proliferation characteristics of prostate tumors in comparison with other malignancies .", "label": "", "metadata": {}, "score": "68.48786"}
{"text": "Conclusion .Prostate IG - IMRT using a daily ERB H2O shows low rates of acute GI toxicity compared to previous reports of air - filled ERB IMRT when using stringent infield rectum constraints and comparable GU toxicities .", "label": "", "metadata": {}, "score": "68.48872"}
{"text": "Study design : YT , KN , MM , SI , YA .Patient contribution , manuscript review : KT , YT , KN , MM , RU , NK , YF , TS , MK , ES , KA , YS , YI , TY , MK , SD , HM , KC , SI , YA , KJ , SY .", "label": "", "metadata": {}, "score": "68.53046"}
{"text": "J Clin Oncol 2007 , 25 : 5366 - 5373 .PubMed View Article .Katz AJ , Santoro M , Ashley R , Diblasio F , Witten M : Stereotactic body radiotherapy as boost for organ - confined prostate cancer .", "label": "", "metadata": {}, "score": "68.62291"}
{"text": "PubMed View Article .Martinez AA , Demanes J , Vargas C , Schour L , Ghilezan M , Gustafson GS : High - dose - rate prostate brachytherapy : an excellent accelerated - hypofractionated treatment for favorable prostate cancer .", "label": "", "metadata": {}, "score": "68.62969"}
{"text": "Materials and Methods : Three institutions included 102 patients with TI - T3N0M0 prostate cancer in a Phase II study .Patients were treated with 56 Gy in 16 fractions over 4 weeks .", "label": "", "metadata": {}, "score": "68.6324"}
{"text": "PubMed View Article .Martin JM , Bayley A , Bristow R , Chung P , Gospodarowicz M , Menard C , Milosevic M , Rosewall T , Warde PR , Catton CN : Image guided dose escalated prostate radiotherapy : still room to improve .", "label": "", "metadata": {}, "score": "68.72885"}
{"text": "Hormonal therapy was prescribed neoadjuvantly and continued concurrently with radiation and adjuvantly for an overall duration of median nine months ( range , 3 - 14 months ) .", "label": "", "metadata": {}, "score": "68.73187"}
{"text": "43 - 54 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Arcangeli , B. Saracino , S. Gomellini et al . , \" A Prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high - risk prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "68.75547"}
{"text": "In this study two different 3DCRT techniques ( WP and PO ) were analyzed and the degree of association was determined between the occurrence and evolution of acute and late GI and GU toxicities and the treatment related characteristics in patients entering our hospital .", "label": "", "metadata": {}, "score": "68.85948"}
{"text": "PubMed View Article .Rogers CL , Alder SC , Rogers RL : High dose brachytherapy as monotherapy for intermediate risk prostate cancer .J Urol 2012 , 187 : 109 - 16 .", "label": "", "metadata": {}, "score": "68.93125"}
{"text": "However , treatment assignment was in all cases at the discretion of the treating physician .Patients were considered ineligible for monotherapy in cases of nodal or other distant metastases , previous pelvic EBRT for another malignant diagnosis or previous open surgery of the prostate .", "label": "", "metadata": {}, "score": "69.049835"}
{"text": "In addition , prior to the acquisition of the treatment planning CT images and 30 minutes before the daily IMRT , each patient urinated to ensure the bladder was in the same state .", "label": "", "metadata": {}, "score": "69.090935"}
{"text": "Int J Radiat Oncol Biol Phys 2012 , 82 : 228 - 234 .PubMed View Article .HT Pham GS , Badiozamani K , Yao M , Corman J , Hsi RA , Madsen B : Five - year Outcome of Stereotactic Hypofractionated Accurate Radiotherapy of the Prostate ( SHARP ) for Patients with Low - risk Prostate Cancer .", "label": "", "metadata": {}, "score": "69.12695"}
{"text": "The parameters that showed univariate significance ( p - value of less than 0.10 ) were input into multivariate models .All statistical analyses were performed using PASW Statistics 17.0 ( SPSS Inc. , Chicago , IL , USA ) .", "label": "", "metadata": {}, "score": "69.13161"}
{"text": "ratio of prostate cancer was comparable to that for late - responding normal tissue or even lower because of the slow natural turnover rates in a high proportion of these tumors [ 5 ] .", "label": "", "metadata": {}, "score": "69.23064"}
{"text": "One of the early experiences using hypofractionation for prostate cancer came from Europe .Over 200 patients were treated at St. Thomas Hospital in London with hypofractionated radiotherapy to a dose of 55 Gy in 12 fractions and later to doses of 36 Gy in 6 fractions with low rectal and urological complications [ 39 , 40 ] .", "label": "", "metadata": {}, "score": "69.26407"}
{"text": "4 , pp .943 - 955 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Arcangeli , B. Saracino , S. Gomellini et al . , \" A Prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high - risk prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "69.2816"}
{"text": "Potters L , Morgenstern C , Calugaru E : 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer .J Urol 2005 , 173 : 1562 - 66 .", "label": "", "metadata": {}, "score": "69.282715"}
{"text": "387 - 392 , 2009 .View at Google Scholar \u00b7 View at Scopus .S. Jabbari , V. K. Weinberg , T. Kaprealian et al . , \" Stereotactic body radiotherapy as monotherapy or post - external beam radiotherapy boost for prostate cancer : technique , early toxicity , and PSA response , \" International Journal of Radiation Oncology , Biology , Physics , vol .", "label": "", "metadata": {}, "score": "69.31126"}
{"text": "The target portion of EBRT was determined one month after seed implantation , and the patients received 45 Gy ( in 25 fractions of 1.8 Gy per fraction ) using a four - field box technique with 6 - 10 MV photon energy .", "label": "", "metadata": {}, "score": "69.36899"}
{"text": "Therefore , the objective of the present study was to contribute to available experience by reporting our mature results of HDR BRT in 351 consecutive patients treated with a hypofractionated two - implant treatment regime .", "label": "", "metadata": {}, "score": "69.4225"}
{"text": "The sexual function changes were more obvious at 12 months but not significant after 24 months .This has to be confirmed with the results of the IIEF - questionnaires .", "label": "", "metadata": {}, "score": "69.67519"}
{"text": "Data analysis , manuscript preparation : KT .All authors reviewed and approved the final manuscript .Multivariate Analysis .GI : .Gastrointestinal .GU : .", "label": "", "metadata": {}, "score": "69.762375"}
{"text": "A portion of the rectal wall located at the level of the PTV and 0.5 cm outside of the PTV on the CT images was contoured .", "label": "", "metadata": {}, "score": "69.80208"}
{"text": "PubMed View Article .Katz AJ , Santoro M , Ashley R , Diblasio F , Witten M : Stereotactic body radiotherapy for organ - confined prostate cancer .", "label": "", "metadata": {}, "score": "69.80977"}
{"text": "PubMed View Article .Kupelian PA , Ciezki J , Reddy CA , Klein EA , Mahadevan A : Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer .", "label": "", "metadata": {}, "score": "69.85672"}
{"text": "Fifty - one patients ( 51 % ) received androgen deprivation therapy for a period no longer than 6 months .The median followup was 66 months .", "label": "", "metadata": {}, "score": "69.86074"}
{"text": "Citrated blood samples from patients were separated by Ficoll - Hypaque 1,077 ( Sigma - Aldrich , St. Louis , MO , USA ) density centrifugation for 40 min to obtain the peripheral blood mononuclear cell ( PBMC ) fraction .", "label": "", "metadata": {}, "score": "69.89388"}
{"text": "The group of King et al .[ 12 ] reported the sexual function during 3 years FU of 32 PC patients having undergone SBRT with 5 fractions of 7.25 Gy .", "label": "", "metadata": {}, "score": "69.9025"}
{"text": "The target volumes included prostate and seminal vesicle without incorporation of regional lymph nodes .All patients received neoadjuvant hormonal therapy for 3 months before radiotherapy to a maximum of 6 months .", "label": "", "metadata": {}, "score": "69.96137"}
{"text": "[ 6 ] demonstrated that it is possible to achieve the same dose distributions with SBRT as with HDR - BT .Based on these findings and our HDR - BT experience , we initiated an SBRT protocol to treat low- and intermediate - risk PC patients .", "label": "", "metadata": {}, "score": "70.0307"}
{"text": "PubMed View Article .Grills IS , Martinez AA , Hollander M : High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds .", "label": "", "metadata": {}, "score": "70.04468"}
{"text": "Cancer 2006 , 107 : 1496 - 1502 .PubMed View Article .Budaus L , Bolla M , Bossi A , Cozzarini C , Crook J , Widmark A , Wiegel T : Functional outcomes and complications following radiation therapy for prostate cancer : a critical analysis of the literature .", "label": "", "metadata": {}, "score": "70.045364"}
{"text": "1200 - 1207 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. F. Fowler , M. A. Ritter , R. J. Chappell , and D. J. Brenner , \" What hypofractionated protocols should be tested for prostate cancer ? \"", "label": "", "metadata": {}, "score": "70.18965"}
{"text": "Even though direct comparisons are difficult , our results are consistent with the experiences of other groups using a similar two - implant approach .Mark et al .", "label": "", "metadata": {}, "score": "70.24419"}
{"text": "The trial was performed over a period of 7 years from 1996 to 2003 at a single centre .Patients were required to have TI or T2 disease , but there were no PSA or Gleason score requirements .", "label": "", "metadata": {}, "score": "70.36565"}
{"text": "S. G. Williams , J. M. G. Taylor , N. Liu et al . , \" Use of individual fraction size data from 3756 patients to directly determine the \u03b1 / \u03b2 ratio of prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "70.3699"}
{"text": "The inclusion criteria can be found in this report as well .Other reasons were : transurethral resection of the prostate in the medical history in six patients ( 12 % ) , pelvic surgery in two ( 4 % ) and hip joint prostheses in five ( 10 % ) .", "label": "", "metadata": {}, "score": "70.37126"}
{"text": "The IIEF results with only 24 months FU are not yet mature for publication [ 12 ] .PR-25 .EORTC QLQ - PR-25 changes ( mean ) .", "label": "", "metadata": {}, "score": "70.377594"}
{"text": "The higher T stage of TNM classification and the acute GI toxicity significantly increased the probability of late GI toxicity occurrence .The results pointed to the significant association of acute GU toxicity and the percentage of the urinary bladder receiving 50 Gy , and the association of late GU toxicity with the percentage of the urinary bladder receiving 40 Gy .", "label": "", "metadata": {}, "score": "70.44186"}
{"text": "The maximum dose heterogeneity allowable in the PTV was 10 % .In the overlap region between the PTV and these critical organs , the constraint was set to 95 % of the prescription dose for the rectum and 95 % for the urethra .", "label": "", "metadata": {}, "score": "70.51467"}
{"text": "It enables 3D anatomy - based optimisation of the dose distribution by accurately controlling the radiation source positioning and modulating source dwell times .This permits excellent target coverage while at the same time minimizing dose to critical structures which can occur with LDR BRT due to source migration and tissue deformities [ 25 ] .", "label": "", "metadata": {}, "score": "70.52329"}
{"text": "Our results brought a new insight into the 3DCRT impact on OARs and the antitumor immune response . dose volume histogram .GI : . gastrointestinal .", "label": "", "metadata": {}, "score": "70.61958"}
{"text": "1106 - 1111 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. D. Thames and H. D. Suit , \" Tumor radioresponsiveness versus fractionation sensitivity , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "70.69133"}
{"text": "A Critical Review , \" Edward F. Miles , W. Robert Lee , Seminars in Radiation Oncology - January 2008 ( Vol .18 , Issue 1 , Pages 41 - 47 , DOI : 10.1016/j.semradonc.2007.09.006 ) .", "label": "", "metadata": {}, "score": "70.74039"}
{"text": "There was hence no statistically significant difference .Again , there was no statistically significant difference .The multivariate Cox regression analyses could not identify independent prognostic factors for biochemical failure .", "label": "", "metadata": {}, "score": "70.775116"}
{"text": "Dosimetry assessment parameters and OAR constraints are shown in Table 2 .Table 2 .Dosimetry parameters of the brachytherapy protocol with total physical prescription dose ( Gy ) and normal tissue dose constraints ( as percentages of the prescribed reference dose ) .", "label": "", "metadata": {}, "score": "70.83069"}
{"text": "Conclusion .Prostate IG - IMRT using a daily ERB H2O shows low rates of acute GI toxicity compared to previous reports of ERB air IMRT when using strict infield rectum constraints and comparable GU toxicities .", "label": "", "metadata": {}, "score": "70.83769"}
{"text": "4 , pp .1034 - 1039 , 1991 .View at Google Scholar \u00b7 View at Scopus .C. D. Collins , \" Radical external beam radiotherapy for localized carcinoma of the prostate using a hypofractionation technique , \" Clinical Oncology , vol .", "label": "", "metadata": {}, "score": "70.862366"}
{"text": "PubMed View Article .Onal C , Topkan E , Efe E , Yavuz M , Sonmez S , Yavuz A : Comparison of rectal volume definition techniques and their influence on rectal toxicity in patients with prostate cancer treated with 3D conformal radiotherapy : a dose - volume analysis .", "label": "", "metadata": {}, "score": "70.98211"}
{"text": "To our best knowledge , this is the first study designed to assess the periodical incidence rates of both GU and GI toxicity in patients who had undergone prostate LDR - brachytherapy .", "label": "", "metadata": {}, "score": "71.0565"}
{"text": "First , the datasets used in the modeling exercise were immature ( potentially resulting in an overestimate of treatment efficacy that was influencing the results of the analysis ) .", "label": "", "metadata": {}, "score": "71.10297"}
{"text": "A daily water - filled endorectal balloon ( ERB H2O ) has been routinely employed in proton therapy for dose distribution optimization [ 11 ] .", "label": "", "metadata": {}, "score": "71.121826"}
{"text": "The EORTC - QLQ PR25 questionnaire is a validated 25-item instrument with four domains ( urinary , bowel , sexual , and hormonal ) , as well as two urinary subscales of incontinence and irritative / bother [ 23 ] .", "label": "", "metadata": {}, "score": "71.143845"}
{"text": "Additional limitations are the tools used for toxicity assessment : CTCAE grading and IPSS .More comprehensive systems , such as the complete Expanded Prostate cancer Index Composite ( EPIC ) [ 22 ] - since implemented in our clinic - may assess subtler , but still clinically relevant morbidity , particularly assessing the bowel function and bother domains .", "label": "", "metadata": {}, "score": "71.1688"}
{"text": "International Journal of Radiation Oncology Biology Physics 73 ( 1 ) : 39 - 45 .APA .Arcangeli , S. , Strigari , L. , Soete , G. , De Meerleer , G. , Gomellini , S. , Fonteyne , V. , Storme , G. , et al .", "label": "", "metadata": {}, "score": "71.21718"}
{"text": ", IJROBP 2003;55:194 - 203 , \" International Journal of Radiation Oncology Biology Physics , vol .57 , no . 2 , pp .593 - 595 , 2003 .", "label": "", "metadata": {}, "score": "71.26997"}
{"text": "More specifically , Lukka et al .[ 25 ] reported on the results of PR 05 , a Canadian randomized trial of 936 patients treated with either 66 Gy in 2 Gy fractions ( long arm ) or 52.5 Gy in 2.625-Gy fractions ( short arm ) .", "label": "", "metadata": {}, "score": "71.46854"}
{"text": "Minimal percentage of the dose received by 90 % of the prostate gland .D90 : .Minimal dose ( Gy ) received by 90 % of the prostate gland .", "label": "", "metadata": {}, "score": "71.52754"}
{"text": "Abstract .Background .To compare the periodical incidence rates of genitourinary ( GU ) and gastrointestinal ( GI ) toxicity in patients who underwent prostate low - dose - rate brachytherapy between the monotherapy group ( seed implantation alone ) and the boost group ( in combination with external beam radiation therapy ( EBRT ) ) .", "label": "", "metadata": {}, "score": "71.578415"}
{"text": "PubMed View Article .Fowler J , Chappell R , Ritter M : Is alpha / beta for prostate tumors really low ?Int J Radiat Oncol Biol Phys 2001 , 50 : 1021 - 31 .", "label": "", "metadata": {}, "score": "71.70429"}
{"text": "PubMed View Article .Zamboglou N , Tselis N , Baltas D : High - dose - rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer : treatment evolution and mature results .", "label": "", "metadata": {}, "score": "71.734146"}
{"text": "( a )Three - dimensional reconstruction of the prostate , organs at risk ( i.e. , rectum , urethra , bladder ) , in situ needles and the intraprostatic source dwell positions as calculated using SWIFT for the final treatment plan .", "label": "", "metadata": {}, "score": "71.7977"}
{"text": "Liao Y , Joiner M , Huang Y , Burmeister J : Hypofractionation : what does it mean for prostate cancer treatment ?Int J Radiat Oncol Biol Phys 2010 , 76 : 260 - 268 .", "label": "", "metadata": {}, "score": "71.86108"}
{"text": "This hypofractionation can also be achieved with stereotactic body radiotherapy ( SBRT ) .We report results on toxicity , PSA response , and quality of life ( QOL ) in patients treated with SBRT for favorable - risk PC .", "label": "", "metadata": {}, "score": "71.93378"}
{"text": "It is estimated that about 30 % of all prostate cancer patients will receive radiotherapy [ 1 ] , and a significant number of these patients will eventually be cured .", "label": "", "metadata": {}, "score": "72.0571"}
{"text": "The required sample size for all performed statistical tests was calculated using IBM SPSS SamplePower software version 3 .Results .Logistic regression models for GI and GU toxicities .", "label": "", "metadata": {}, "score": "72.07567"}
{"text": "Retrospective Clinical Trials with Hypofractionated Radiotherapy for Prostate Cancer .Hypofractionated radiotherapy regimens have been used for several decades , primarily due to the low availability of treatment machines .", "label": "", "metadata": {}, "score": "72.24674"}
{"text": "PubMed View Article .Lancet 2002 , 360 ( 9327 ) : 103 - 106 .PubMed View Article . D'AmicoAV , Chen MH , Renshaw AA , Loffredo M , Kantoff PW : Androgen suppression and radiation vs radiation alone for prostate cancer : a randomized trial .", "label": "", "metadata": {}, "score": "72.27867"}
{"text": "This patient had a baseline prostate volume of 110 cc ; the maximum prostate volume allowed was lowered to 90 cc in our protocol following this incident .", "label": "", "metadata": {}, "score": "72.33"}
{"text": "PubMed View Article .Li XA , Yu C , Holmes T : A systematic evaluation of air cavity dose perturbation in megavoltage x - ray beams .", "label": "", "metadata": {}, "score": "72.461266"}
{"text": "PubMed View Article .Van Lin EN , van der Vight LP , Witjes JA , Huisman HJ , Leer JW , Visser AG : The effect of an endorectal balloon and off - line correction on the interfraction systematic and random prostate position variations : a comparative study .", "label": "", "metadata": {}, "score": "72.598495"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. T. Pham , G. Song , K. Badiozamani , et al . , \" Five - year outcome of stereotactic hypofractionated accurate radiotherapy of the prostate ( SHARP ) for patients with low - risk prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "72.64159"}
{"text": "PubMed .Katz AJ , Santoro M , Ashley R , Diblasio F , Witten M : Stereotactic body radiotherapy for organ - confined prostate cancer .", "label": "", "metadata": {}, "score": "72.69226"}
{"text": "Follow - up and statistical analysis .Initial follow - up was performed at six weeks after the last BRT fraction and then every three months for the first year , every six months for the second year and annually thereafter .", "label": "", "metadata": {}, "score": "72.70758"}
{"text": "The PSA response to date is good without any BF .More patients and longer FU is needed to confirm this conclusion .Declarations .Acknowledgements .", "label": "", "metadata": {}, "score": "72.77373"}
{"text": "Several studies of the radiobiology of prostate cancer suggest that it may be more susceptible to large fraction sizes compared with conventional fractionation of external beam radiation .", "label": "", "metadata": {}, "score": "72.78429"}
{"text": "Hypofractionated radiotherapy for prostate cancer has become of increasing interest with the recognition of a potential improvement in therapeutic outcome with treatments delivered in large - sized daily fractions .", "label": "", "metadata": {}, "score": "72.81415"}
{"text": "Particularly , Hsp72 can act as an immunological adjuvant [ 39 , 40 ] , participating in the non - self recognition of prostate cancer cells .", "label": "", "metadata": {}, "score": "72.955475"}
{"text": "To our best knowledge , this is the first study designed to assess the periodical incidence rates of both GU and GI toxicity in patients who underwent prostate LDR - brachytherapy .", "label": "", "metadata": {}, "score": "72.991196"}
{"text": "MLA .Arcangeli , Stefano , Lidia Strigari , Guy Soete , et al . \"CLINICAL AND DOSIMETRIC PREDICTORS OF ACUTE TOXICITY AFTER A 4-WEEK HYPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY REGIMEN FOR PROSTATE CANCER : RESULTS FROM A MULTICENTRIC PROSPECTIVE TRIAL . \" INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 73.1 ( 2009 ) : 39 - 45 .", "label": "", "metadata": {}, "score": "73.03748"}
{"text": "PubMed View Article .Deville C , Both S , Hwang WT , Tochner Z , Vapiwala N : Clinical toxicities and dosimetric parameters after whole - pelvis versus prostate - only intensity - modulated radiation therapy for prostate cancer .", "label": "", "metadata": {}, "score": "73.06804"}
{"text": "PubMed View Article .Van Esch A , Tillikainen L , Pyykkonen J , Tenhunen M , Helminen H , Siljam\u00e4ki S , Alakuijala J , Paiusco M , Lori M , Huyskens DP : Testing of the analytical anisotropic algorithm for photon dose calculation .", "label": "", "metadata": {}, "score": "73.06833"}
{"text": "All patients were treated with tomotherapy or linac based IMRT with daily image guidance .Three hundred seven patients with favorable to intermediate risk prostate cancer was accrued .", "label": "", "metadata": {}, "score": "73.10156"}
{"text": ", IJROBP 2001;50:1021 - 1031 , \" International Journal of Radiation Oncology Biology Physics , vol .52 , no .5 , pp .1427 - 1428 , 2002 .", "label": "", "metadata": {}, "score": "73.10267"}
{"text": "However trials are warranted addressing many of the raising questions about the optimal fraction dose , total dose , safety constraints and the optimal technique to be used .", "label": "", "metadata": {}, "score": "73.127304"}
{"text": "We have to remember that some of these pre - existing symptoms could have been erroneously interpreted as acute or even late GU toxicity .On the other hand , late bladder damage can occur with a long latency time , potentially resulting in the underestimation of the real severity of late toxicity [ 30 ] .", "label": "", "metadata": {}, "score": "73.140976"}
{"text": "Kuldova M , Svoboda J , Kovaru F , Vannucci L , Kovaru H , Fiserova A : NK cell - mediated cytotoxicity modulation by A(2 ) adenosine receptor agonist in different mammalian species .", "label": "", "metadata": {}, "score": "73.14754"}
{"text": "Isodose distribution after anatomy - based dose optimisation .The 100 % isodose was set to encompass the red delineated prostate capsule .All implants were performed under spinal , or if indicated , general anaesthesia with the patient in the high lithotomy position using a perineal template .", "label": "", "metadata": {}, "score": "73.17285"}
{"text": "15 , pp .2020 - 2026 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. Pollack , Five Year Results of a Randomized External Beam Radiotherapy Hypofractionation Trial for Prostate Cancer-(Pleneary Session ) , ASTRO , Miami , Fla , USA , 2011 . E. E. Yeoh , R. H. Holloway , R. J. Fraser et al . , \" Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma : updated results of a phase III randomized trial , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "73.294846"}
{"text": "PubMed View Article .Wehle MJ , Lisson SW , Buskirk SJ , Broderick GA , Young PR , Igel TC : Prediction of genitourinary tract morbidity after brachytherapy for prostate adenocarcinoma .", "label": "", "metadata": {}, "score": "73.33619"}
{"text": "SBRT can be delivered safely using any of several commercially available treatment systems .In some cases the dose delivery involves a combination of multiple non - coplanar beams aimed at the target , and in other systems the delivery is accomplished with static intensity - modulated beams or rotating modulated arcs .", "label": "", "metadata": {}, "score": "73.36601"}
{"text": "In the final questionnaire 293 patients ( 83.4 % ) reported an erection adequate for intercourse achieved with or without the use of erectile aids .", "label": "", "metadata": {}, "score": "73.44616"}
{"text": "The dose was delivered in daily fractions of 1.8 Gy to the pelvis and of 2 Gy to the prostate and seminal vesicles , in given period five sessions per week .", "label": "", "metadata": {}, "score": "73.51491"}
{"text": "PubMed View Article .Brachytherapy 2009 , 8 : 191 - 196 .PubMed View Article .Aoki M , Miki K , Sasaki H , Kido M , Shirahama J , Takagi S , Kobayashi M , Honda C , Kanehira C : Evaluation of rectal bleeding factors associated with prostate brachytherapy .", "label": "", "metadata": {}, "score": "73.58679"}
{"text": "PubMed View Article .Smeenk RJ , Louwe RJ , Langen KM , Shah AP , Kupelian PA , van Lin EN , Kaanders JH : An endorectal balloon reduces intrafraction prostate motion during radiotherapy .", "label": "", "metadata": {}, "score": "73.59554"}
{"text": "PubMed View Article . D'AmicoAV , Whittington R , Malkowicz SB : Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era .", "label": "", "metadata": {}, "score": "73.74524"}
{"text": "IBM : . iliac bone marrow .ICRU : .International Commission on Radiation Units .LENT - SOMA : .Late effects in Normal Tissues Subjective , Objective , Management and Analytical scales .", "label": "", "metadata": {}, "score": "73.7568"}
{"text": "The transperineal approach in high dorsal lithotomy position enables adequate implantation of volumes appreciably greater than 50 cc provided there is a sufficiently broad pelvic inlet and low pre - treatment urinary symptom scores .", "label": "", "metadata": {}, "score": "73.83942"}
{"text": "The reported 94 % BC at 60 months is in accordance with mature HDR monotherapy data from other institutions , suggesting high PSA relapse - free survival rates for all risk groups .", "label": "", "metadata": {}, "score": "74.04784"}
{"text": "International Journal of Radiation Oncology Biology Physics , vol .56 , no .4 , pp .1093 - 1104 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. A. Loblaw and P. Cheung , \" External beam irradiation for localized prostate cancer - the promise of hypofractionation , \" The Canadian Journal of Urology , vol .", "label": "", "metadata": {}, "score": "74.04831"}
{"text": "Before the therapy , patient set - up was checked using electronic portal imaging ( PortalVision PV - aS500 \u00ae ) .Simulator images of setup fields were used as reference images for matching with portal images .", "label": "", "metadata": {}, "score": "74.1199"}
{"text": "SBRT .Published results of SBRT as monotherapy reported a short FU and many variations in fraction size , total dose , and technique used .", "label": "", "metadata": {}, "score": "74.21613"}
{"text": "Cell Stress Chaperones 2010 .Nausch N , Cerwenka A : NKG2D ligands in tumor immunity .Oncogene 2008 , 27 : 5944 - 5958 .", "label": "", "metadata": {}, "score": "74.217316"}
{"text": "Dose volume histograms ( DVHs ) for prostate , urethra , and rectum were calculated for evaluation of the anatomy - based dose optimisation .As the preplanning dosimetry parameters fulfilled our dosimetric protocol ( Table 2 ) , TRUS guided implantation of steel needles ( 200 mm length , 1.9 mm diameter ) was performed at the previously determined positions .", "label": "", "metadata": {}, "score": "74.280975"}
{"text": "The plans , using MLC to shape beams , were calculated on Eclipse treatment planning system .Box technique or four wedged field technique ( two lateral and two oblique fields at angles of 90 \u00b0 , 270 \u00b0 , 30 \u00b0 and 330 \u00b0 ) was used .", "label": "", "metadata": {}, "score": "74.341644"}
{"text": "T and NKT cells were down - regulated throughout the whole period .We found a negative correlation between leukocyte numbers and bone marrow irradiated by 44 - 54 Gy and a positive one for NK cell proportion and doses of 5 - 25 Gy .", "label": "", "metadata": {}, "score": "74.38876"}
{"text": "To compare the immune parameters between these groups of patients the t - test was performed .To find the relationship between immune response in prostate cancer patients and treatment related factors , Pearson 's correlation coefficients were calculated .", "label": "", "metadata": {}, "score": "74.43283"}
{"text": "Before the radiotherapy , the treatment plans were simulated on a conventional simulator ( Ximatron and Acuity \u00ae , Varian Medical Systems ) .The isocenter was marked on the patient 's skin .", "label": "", "metadata": {}, "score": "74.44519"}
{"text": "Int J Radiat Oncol Biol Phys 2006 , 64 : 1140 - 1150 .PubMed View Article .Alcantara P , Hanlon A , Buyyounouski MK , Horwitz EM , Pollack A : Prostate - specific antigen nadir within 12 months of prostate cancer radiotherapy predicts metastasis and death .", "label": "", "metadata": {}, "score": "74.45509"}
{"text": "Recently , radiation - induced functional changes in immune cells raised interest , suggesting the possible use of radiation as an antitumor immune response enhancer .", "label": "", "metadata": {}, "score": "74.479675"}
{"text": "PubMed View Article .Bria E , Cuppone F , Giannarelli D , Milella M , Ruggeri EM , Sperduti I , Pinnaro P , Terzoli E , Cognetti F , Carlini P : Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer ?", "label": "", "metadata": {}, "score": "74.67723"}
{"text": "4 , pp .240 - 243 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. W. Lloyd - Davies , C. D. Collins , and A. V. Swan , \" Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation .", "label": "", "metadata": {}, "score": "74.814804"}
{"text": "PubMed View Article .Teh BS , Dong L , McGary JE , Mai WY , Grant W , Butler EB : Rectal wall sparing by dosimetric effect of rectal balloon used during intensity - modulated radiation therapy ( IMRT ) for prostate cancer .", "label": "", "metadata": {}, "score": "74.84918"}
{"text": "Multivariate analysis showed that the International Prostate Symptom Score ( IPSS ) before seed implantation was a significant parameter to predict acute GU toxicity , while there were no significant predictive parameters for acute GI toxicity .", "label": "", "metadata": {}, "score": "74.91756"}
{"text": "Biochemical failure ( BF ) was determined according to the Phoenix definition ( nadir PSA + 2 ng / ml ) [ 9 ] .A PSA bounce is defined as a transient rise in the PSA level with a subsequent normalization of the PSA values [ 10 ] .", "label": "", "metadata": {}, "score": "74.92409"}
{"text": "Patients had histologically - confirmed , clinically localized prostate adenocarcinoma evaluated by complete history , physical examination including digital rectal examination , bone scintigraphy , and computed tomography ( CT ) of the abdomen and pelvis and/or pelvic magnetic resonance imaging ( MRI ) \u00b1 endorectal coil .", "label": "", "metadata": {}, "score": "74.93231"}
{"text": "In recent years there has been increasing interest in hypofractionated radiotherapy for prostate cancer .A significant number of reports have suggested that .ratio for prostate cancer is low .", "label": "", "metadata": {}, "score": "75.01751"}
{"text": "There was no statistically significant difference between these risk groups , indicating that all patients benefited equally .At this point , the potential advantage of short term androgen suppression for high - risk patients remains an issue of ongoing discussion as no corroborative evidence exclusive to this modality exists .", "label": "", "metadata": {}, "score": "75.09534"}
{"text": "Freedom from biochemical recurrence ( FFBR ) was calculated according to the American Society for Therapeutic Radiology and Oncology consensus definition [ 19 ] .Freedom from biochemical recurrence at 5 years was 82 % , 56 % , and 39 % for the low- , intermediate- , and high - risk groups , respectively .", "label": "", "metadata": {}, "score": "75.11478"}
{"text": "PSA nadir and bounce .PSA bounce was recorded in seven patients ( 14 % ) , and the mean interval to the bounce episode was 12 months ( range , 4.0 - 22 months ) .", "label": "", "metadata": {}, "score": "75.18698"}
{"text": "62 - 66 , 2006 .View at Google Scholar \u00b7 View at Scopus .S. G. Williams , J. M. G. Taylor , N. Liu et al . , \" Use of individual fraction size data from 3756 patients to directly determine the \u03b1 / \u03b2 ratio of prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "75.2584"}
{"text": "The standard 51 Cr - release assay was performed with PBMCs from patients as effectors and the NK cell - sensitive K562 erythroleukemia cell line as targets .", "label": "", "metadata": {}, "score": "75.26712"}
{"text": "The Memorial Sloan Kettering group definition was used to classify patients into risk groups [ 18 ] .Eligibility criteria were clinically and radiographically organ - confined disease with freedom from lower urinary tract symptoms requiring treatment .", "label": "", "metadata": {}, "score": "75.3157"}
{"text": "Both of these subpopulations returned to normal values or decreased after completing RT .In contrast , T lymphocytes were decreased during RT and normalized after its completion ; while NKT cells were down - regulated in all time periods .", "label": "", "metadata": {}, "score": "75.31909"}
{"text": ": Recommendations of the International Consensus Committee concerning patient evaluation for research studies .In Proceedings of the International Consultation on Benign Prostatic Hyperplasia ( BPH ) .", "label": "", "metadata": {}, "score": "75.371826"}
{"text": "Conclusions .We report the medium - term treatment outcomes of high - dose image - guided IMRT for patients with localized prostate cancer .The current treatment is well tolerated and appears to provide valuable biochemical tumor control .", "label": "", "metadata": {}, "score": "75.45377"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. J. Hall and D. J. Brenner , \" The radiobiology of radiosurgery : rationale for different treatment regimes for AVMs and malignancies , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "75.52401"}
{"text": "PubMed View Article .Yamada Y , Rogers L , Demanes DJ : American Brachytherapy Society consensus guidelines for high - dose - rate prostate brachytherapy .", "label": "", "metadata": {}, "score": "75.52846"}
{"text": "All 351 patients had histologically proven disease and were staged according to the American Joint Committee on Cancer , 6 th edition , staging guidelines .", "label": "", "metadata": {}, "score": "75.54723"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Tsuji , T. Yanagi , H. Ishikawa et al . , \" Hypofractionated radiotherapy with carbon ion beams for prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "75.55933"}
{"text": "In spite of this focus , a higher dose to the prostate implies that the surrounding organs at risk ( OARs ) may also receive higher doses .", "label": "", "metadata": {}, "score": "75.59665"}
{"text": "PubMed View Article .Roach M , Hanks G , Thames H : Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer : recommendations of the RTOG - ASTRO Phoenix Consensus Conference .", "label": "", "metadata": {}, "score": "75.734695"}
{"text": "for prostate was \" atypically \" low .Brenner and Hall [ 14 ] suggested in 1999 that prostate tumors might not respond to changes in fractionation in the same way as other cancers .", "label": "", "metadata": {}, "score": "75.73874"}
{"text": "PubMed View Article .van der Wielen GJ , van Putten WL , Incrocci L : Sexual function after three - dimensional conformal radiotherapy for prostate cancer : results from a dose - escalation trial .", "label": "", "metadata": {}, "score": "75.840034"}
{"text": "PubMed View Article .Zelefsky MJ , Yamada Y , Cohen GN , Sharma N , Shippy AM , Fridman D , Zaider M : Intraoperative real - time planned conformal prostate brachytherapy : post - implantation dosimetric outcome and clinical implications .", "label": "", "metadata": {}, "score": "75.90728"}
{"text": "PubMed View Article .Song JS , Court LE , Cormack RA : Monte Carlo calculation of rectal dose when using an intrarectal balloon during prostate radiation therapy .", "label": "", "metadata": {}, "score": "75.953"}
{"text": "Udono H , Srivastava PK : Comparison of tumor - specific immunogenicities of stress - induced proteins gp96 , hsp90 , and hsp70 .J Immunol 1994 , 152 : 5398 - 5403 .", "label": "", "metadata": {}, "score": "76.03502"}
{"text": "Patients received androgen suppression for 3 - 6 months before and during radiotherapy , but it was optional for men with low - risk disease .", "label": "", "metadata": {}, "score": "76.08772"}
{"text": "PubMed View Article .Vargas C , Mahajan C , Fryer A , et al .: Rectal dose - volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer .", "label": "", "metadata": {}, "score": "76.12962"}
{"text": "Keywords .Image - guided radiotherapy Prostate cancer Biochemical control Toxicity .Background .Recently , several studies have confirmed the advantages of delivering high doses of external beam radiotherapy ( EBRT ) to achieve optimal tumor - control outcomes in patients with localized prostate cancer .", "label": "", "metadata": {}, "score": "76.34574"}
{"text": "PubMed View Article .Fiorino C , Sanguineti G , Cozzarini C , Fellin G , Foppiano F , Menegotti L , Piazzolla A , Vavassori V , Valdagni R : Rectal dose - volume constraints in high - dose radiotherapy of localized prostate cancer .", "label": "", "metadata": {}, "score": "76.56766"}
{"text": "[ 12 - 14 ] or radical prostatectomy [ 15 ] .In the absence of randomised clinical trials of sufficient size , however , the optimal therapeutic strategy for organ - confined disease remains controversial and treatment assignment appears influenced by physician bias and patient preference .", "label": "", "metadata": {}, "score": "76.59674"}
{"text": "We assume that these changes are caused by stress conditions induced by RT - damaged and GI or GU toxicity - affected tissues , eliciting stimulation of cytotoxic cells ( NK and CTLs ) .", "label": "", "metadata": {}, "score": "76.6465"}
{"text": "PubMed View Article .Ebert MA , Spry NA : Dose perturbation by air cavities in megavoltage photon beams : implications for cavity surface doses .", "label": "", "metadata": {}, "score": "76.69025"}
{"text": "ratio , defined as the dose at which killing of cell by linear ( . and quadratic ( .components are equal , is used to quantify the fractionation sensitivity of tissues and tumors .", "label": "", "metadata": {}, "score": "76.89508"}
{"text": "Several publications suggest a radiobiological rationale for hypofractionated radiotherapy in PC [ 1 , 2 ] .This indicates a high sensitivity of PC to fraction dose but not to the total dose , suggesting the possibility of significant therapeutic benefit from hypofractionation in terms of local control and reduction of normal tissue complication probability for bladder and rectum [ 1 - 3 ] .", "label": "", "metadata": {}, "score": "76.93213"}
{"text": "JAMA 1997 , 277 : 1445 - 1451 .PubMed View Article .Int J Radiat Oncol Biol Phys 2008 , 70 : 1431 - 1437 .", "label": "", "metadata": {}, "score": "76.99423"}
{"text": "Urethra contouring encountered the intraprostatic urethra marked by the insertion of a three - way Foley catheter and extended by 5 mm caudally to include the apical urethra membrane .", "label": "", "metadata": {}, "score": "77.04645"}
{"text": "Brenner DJ , Hall EJ : Fractionation and protraction for radiotherapy of prostate carcinoma .Int J Radiat Oncol Biol Phys 1999 , 43 : 1095 - 101 .", "label": "", "metadata": {}, "score": "77.10864"}
{"text": "PubMed View Article .Cannistra SA , Griffin JD : Regulation of the production and function of granulocytes and monocytes .Semin Hematol 1988 , 25 : 173 - 188 .", "label": "", "metadata": {}, "score": "77.28702"}
{"text": "PubMed View Article .Roach M 3rd , Lu J , Pilepichm V , Asbell SO , Mohiuddin M , Terry R , Grignon D , Lawton C , Shipley W , Cox J : Predicting long - term survival , and the need for hormonal therapy : a meta - analysis of RTOG prostate cancer trials .", "label": "", "metadata": {}, "score": "77.316605"}
{"text": "PubMed View Article .Zelefsky MJ , Yamada Y , Fuks Z : Long - term results of conformal radiotherapy for prostate cancer : impact of dose escalation on biochemical tumor control and distant metastases - free survival outcomes .", "label": "", "metadata": {}, "score": "77.35317"}
{"text": "Treatment .Of all the patients , 149 did not receive neoadjuvant or adjuvant androgen deprivation therapy ( ADT ) , 4 received both neoadjuvant and adjuvant ADT , 60 received only neoadjuvant ADT , and 5 received only adjuvant ADT .", "label": "", "metadata": {}, "score": "77.50531"}
{"text": "PubMed .Int J Radiat Oncol Biol Phys 2003 , 57 ( 4 ) : 929 - 943 .PubMed View Article .Roach M 3rd , Hanks G , Thames H , Schellhammer P , Shipley WU , Sokol GH , Sandler H : Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer : recommendations of the RTOG - ASTRO Phoenix Consensus Conference .", "label": "", "metadata": {}, "score": "77.5353"}
{"text": "Hypofractionated External - Beam Radiotherapy for Prostate Cancer .Received 30 April 2012 ; Accepted 13 October 2012 .Academic Editor : Rami Ben - Yosef .", "label": "", "metadata": {}, "score": "77.5677"}
{"text": "The SBRT technique consisted of intensity - modulated radiotherapy ( IMRT ) with daily image guidance using implanted gold fiducials .All patients had at least 6 months of follow - up .", "label": "", "metadata": {}, "score": "77.63514"}
{"text": "Milickovic N , Mavroidis P , Tselis N : 4D analysis of influence of patient movement and anatomy alteration on the quality of 3D U / S - based prostate HDR brachytherapy treatment delivery .", "label": "", "metadata": {}, "score": "77.663155"}
{"text": "IPSS before seed implantation and neoadjuvant ADT remained as predictive parameters for acute GU toxicity in the univariate analysis .In the multivariate analysis , IPSS before seed implantation was a significant predictive parameter for acute GU toxicity , and there was no significant predictive parameter for acute GI toxicity .", "label": "", "metadata": {}, "score": "77.67731"}
{"text": "WH and KT participated in its design , carried out the statistical analyses , and helped to draft the manuscript .All authors read and approved the final manuscript .", "label": "", "metadata": {}, "score": "77.68475"}
{"text": "Pelvic lymph node dissection ( PLND ) was performed in 45 patients ( 32 % ) to rule out metastatic disease .Abbreviations : PSA , prostate - specific antigen ; NCCN , national comprehensive cancer network ; IR , intermediate risk ; HR , high risk ; ADT , androgen - deprivation therapy ; STADT , short - term ADT ; LTADT , long - term ADT .", "label": "", "metadata": {}, "score": "77.73172"}
{"text": "After completion of RT the NK and NKT cells were found to be more sensitive to higher doses .However , positive correlation was found between differentiating B lymphocytes , and the irradiated volume of rectum and bladder receiving 70 Gy .", "label": "", "metadata": {}, "score": "77.762436"}
{"text": "PubMed View Article .Ray ME , Thames HD , Levy LB , Horwitz EM , Kupelian PA , Martinez AA , Michalski JM , Pisansky TM , Shipley WU , Zelefsky MJ , et al .", "label": "", "metadata": {}, "score": "78.06031"}
{"text": "We have described for the first time the correlation between organs at risk , dose - volume parameters , and the immunological profile .3-dimensional conformal radiotherapy ( 3DCRT ) gastrointestinal and genitourinary toxicity prostate cancer NK cells PTV parameters pelvic bone marrow .", "label": "", "metadata": {}, "score": "78.1579"}
{"text": "Pearson 's correlation coefficients of immune cells proportions with dosimetric parameters .All statistically significant correlation coefficients met the conditions of required sample size .The GI and GU toxicity side effects ( after the completion of 3DCRT ) , but not 3DCRT itself , significantly decreased the distribution of NKT cells in the WP group ( Figure 4A ) .", "label": "", "metadata": {}, "score": "78.18035"}
{"text": "Methods .In total , 141 patients with localized prostate cancer treated with image - guided IMRT ( 76 Gy in 13 patients and 80 Gy in 128 patients ) between 2003 and 2008 were enrolled in this study .", "label": "", "metadata": {}, "score": "78.24322"}
{"text": "PubMed View Article .Boike TP , Lotan Y , Cho LC , Brindle J , DeRose P , Xie XJ , Yan J , Foster R , Pistenmaa D , Perkins A , et al .", "label": "", "metadata": {}, "score": "78.28421"}
{"text": "There is convincing evidence , by several clinical trials , that biochemical control is significantly improved with higher administered radiation doses to the prostate gland .", "label": "", "metadata": {}, "score": "78.34665"}
{"text": "PubMed View Article .Int J Radiat Oncol Biol Phys .PubMed View Article .Michalski JM , Gay H , Jackson A , Tucker SL , Deasy JO : Radiation dose - volume effects in rad iation - induced rectal injury .", "label": "", "metadata": {}, "score": "78.3509"}
{"text": "Percentage prostate volume receiving 100 % and 150 % of the prescribed minimal peripheral dose .UD30 : .Minimal dose ( Gy ) by 30 % of the urethra .", "label": "", "metadata": {}, "score": "78.42057"}
{"text": "In all patients , four gold fiducial seeds were implanted in the prostate through ultrasound - guided trans - perineal pre - loaded needles .One week after fiducial implantation , computed tomography ( CT ) and magnetic resonance images ( MRI ) were acquired .", "label": "", "metadata": {}, "score": "78.554504"}
{"text": "While conventional fractionation radiation regimens are usually employing fractions of 1.8 - 2.0 Gy daily , hypofractionation , as the name suggests , refers to the delivery of radiotherapy dose in smaller number of treatments that would be used to deliver a traditional dosing scheme .", "label": "", "metadata": {}, "score": "78.61098"}
{"text": "More specifically , if .ratio for prostate cancer is lower than the nearby normal tissues , then the therapeutic advantage can be gained by using fewer and larger fractions .", "label": "", "metadata": {}, "score": "78.64793"}
{"text": "Besides the healthcare systems , prostate cancer is considered to have an impact on society as well , as far as biologic , economic , and personal parameters are concerned .", "label": "", "metadata": {}, "score": "78.72347"}
{"text": "D ' Amico AV , Manola J , Loffredo M , et al .: A practical method to achieve prostate gland immobilization and target verification for daily treatment .", "label": "", "metadata": {}, "score": "78.87343"}
{"text": "PubMed View Article .Goldner G , Geinitz H , Wachter S , et al .: 3-D Conformal radiotherapy of localized prostate cancer within an Austrian - German multicenter trial : a prospective study of patients ' acceptance of the rectal balloon during treatment .", "label": "", "metadata": {}, "score": "79.00525"}
{"text": "Our fractionation scheme was used in HDR - brachytherapy series with excellent 10-year results [ 5 ] .Despite such good results , the invasive character and the need of hospitalization and anesthesia makes brachytherapy less convenient and a labor intensive method .", "label": "", "metadata": {}, "score": "79.238525"}
{"text": "Some pathological changes can be caused by the apoptosis of bone marrow ( BM ) stem cells and BM stromal damage [ 13 ] .Radiation - induced BM injury depends on both the radiation dose and the volume of BM irradiated [ 14 ] .", "label": "", "metadata": {}, "score": "79.38327"}
{"text": "Measurement and subsequent analysis was performed using FACSDiva ( BD Biosciences ) and TreeStar FlowJo 8 ( Ashland , OR , USA ) software , respectively .", "label": "", "metadata": {}, "score": "79.396164"}
{"text": "PubMed View Article .Wiegner EA , King CR : Sexual function after stereotactic body radiotherapy for prostate cancer : results of a prospective clinical trial .", "label": "", "metadata": {}, "score": "79.48966"}
{"text": "Quality of life is becoming one of the most significant issues in treatment decision - making , in general , and more so in prostate cancer [ 1 ] .", "label": "", "metadata": {}, "score": "79.50107"}
{"text": "An air - filled endorectal balloon ( ERB air ) has been used in photon therapy for the potential anterior rectal wall ( ARW ) surface - sparing effect .", "label": "", "metadata": {}, "score": "79.51201"}
{"text": "Authors ' contributions .NT , UT and NZ performed study conception and design .NT , GC , MR and NM performed data collection , analysis and interpretation .", "label": "", "metadata": {}, "score": "79.79103"}
{"text": "PubMed .Britton KR , Takai Y , Mitsuya M , Nemoto K , Ogawa Y , Yamada S : Evaluation of inter- and intrafraction organ motion during intensity - modulated radiation therapy ( IMRT ) for localized prostate cancer measured by a newly developed on - board image - guided system .", "label": "", "metadata": {}, "score": "79.85002"}
{"text": "Written informed consent was obtained from all patients .In our series we had one patient with T3 disease , who was staged T3a .The PTV in this case was defined by the prostate capsule plus 5.0 mm in all directions ( except for the posterior rectal margin ) .", "label": "", "metadata": {}, "score": "79.87105"}
{"text": "[ 22 ] reported on the National Institute of Radiological Sciences experience on 201 patients using carbon ion therapy in the hypofractionated treatment of prostate cancer during three clinical trials in Japan from June 1995 to February 2004 .", "label": "", "metadata": {}, "score": "80.03891"}
{"text": "Abstract .Background .Methods .We analyzed 197 prostate cancer patients undergoing 3DCRT for gastrointestinal ( GI ) and genitourinary ( GU ) toxicities , and conducted a pilot immunological study including flow cytometry and an NK cell cytotoxicity assay .", "label": "", "metadata": {}, "score": "80.07"}
{"text": "The most common GU complaints during this phase were urinary urge and increased night voiding frequency .Increased stool frequency was the main GI complaint .", "label": "", "metadata": {}, "score": "80.23188"}
{"text": "Abbreviations : RT , radiotherapy ; M , months ; LR , low risk ; PD , Phoenix Consensus definition ; AD , American Society for Therapeutic Radiology and Oncology definition ; other abbreviations as in Table 1 .", "label": "", "metadata": {}, "score": "80.31635"}
{"text": "Hypofractionated external beam radiotherapy has been used clinically for a number of years , particularly in the UK [ 2 - 4 ] .Given that quality of life has become one of the most significant issues in treatment decisions in prostate cancer , hypofractionation offers a shorter treatment course and increases convenience for prostate cancer patients .", "label": "", "metadata": {}, "score": "80.363556"}
{"text": "There are radiobiological rationales supporting hypofractionated radiotherapy for prostate cancer .The recent advancements in treatment planning and delivery allow sophisticated radiation treatments to take advantage of the differences in radiobiology of prostate cancer and the surrounding normal tissues .", "label": "", "metadata": {}, "score": "80.39661"}
{"text": "PubMed View Article .A Phase III Trial Comparing Whole Pelvic Irradiation Followed by a Conedown Boost to Boost Irradiation Only and Comparing Neoadjuvant to Adjuvant Total Androgen Suppression ( TAS ) 2011 .", "label": "", "metadata": {}, "score": "80.44737"}
{"text": "The reason is that the tumor cell response , proportional to the BED as determined in the equation above , is generally less influenced by fraction size than is the BED for the late - responding normal tissues that surround the targeted tumor .", "label": "", "metadata": {}, "score": "80.44737"}
{"text": "View Article .Both S , Wang KK , Plastaras JP , Deville C , Bar Ad V , Tochner Z , Vapiwala N : Real - Time Study of Prostate Intrafraction Motion During External Beam Radiotherapy With Daily Endorectal Balloon .", "label": "", "metadata": {}, "score": "80.568375"}
{"text": "There were no associations with bladder or bladder wall DVH parameters .Similarly , the Baylor group found no relationship between acute GU toxicity and bladder DVH parameters [ 14 ] , corroborating reports that bladder DVH parameters generally do not consistently correlate with acute or late GU toxicities .", "label": "", "metadata": {}, "score": "80.58477"}
{"text": "PubMed View Article .De Maio A : Extracellular heat shock proteins , cellular export vesicles , and the Stress Observation System : A form of communication during injury , infection , and cell damage : It is never known how far a controversial finding will go !", "label": "", "metadata": {}, "score": "80.658646"}
{"text": "Median International Prostate Symptoms Score ( IPSS ) was 9/35 before treatment , with a median increase of 4 at 3 months and remaining stable at 13/35 thereafter .", "label": "", "metadata": {}, "score": "80.84333"}
{"text": "This is in contrast to our technique , which was also used by Jabbari [ 21 ] administering four daily fractions of 9.5 Gy , where the dose distribution inside the prostate is heterogeneous up to 40 % above the PD .", "label": "", "metadata": {}, "score": "81.03146"}
{"text": "King CR , Fowler JF : A simple analytic derivation suggests that prostate cancer alpha / beta ratio is low .Int J Radiat Oncol Biol Phys 2001 , 51 : 213 - 214 .", "label": "", "metadata": {}, "score": "81.06062"}
{"text": "Methods .Between 2003 and 2008 , 150 patients with localized prostate cancer were treated with image- guided IMRT at Tohoku University Hospital .Among these patients , 141 patients who satisfied the eligibility criteria were included in the current study and retrospectively analyzed .", "label": "", "metadata": {}, "score": "81.106255"}
{"text": "Radiotherapy planning and delivery .Planning CT was performed at minimum 4 days after implantation on a CT simulator ( Siemens USA , New York , NY ) .", "label": "", "metadata": {}, "score": "81.27659"}
{"text": "Both PTVs were enlarged by 1.5 cm margin , except for the prostate - rectum interface where a 1 cm margin was again used to decrease the risk of rectal toxicity .", "label": "", "metadata": {}, "score": "81.28912"}
{"text": "Although many patients have been successfully treated with radiotherapy regimens of this nature , the optimal radiation schedule for the curative treatment of prostate cancer remains an unsettled question .", "label": "", "metadata": {}, "score": "81.311356"}
{"text": "Finally , the presence of seminal vesicle invasion or large prostate gland volumes extending beyond the bony pelvic inlet , also disqualify patients for monotherapy [ 28 ] .", "label": "", "metadata": {}, "score": "81.34937"}
{"text": "Prospective Randomized Clinical Trials Comparing Different Radiation Regimens .Two randomized , controlled trials that have been published compared radiation regimens with different daily fraction sizes in patients with clinically localized prostate cancer .", "label": "", "metadata": {}, "score": "81.43766"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. F. Fowler , M. A. Ritter , J. D. Fenwick , and R. J. Chappell , \" How low is the \u03b1 / \u03b2 ratio for prostate cancer ?", "label": "", "metadata": {}, "score": "81.65549"}
{"text": "Introduction .Prostate cancer is the most common cancer diagnosed in American men after non - melanomatous skin cancer .According to the American Cancer Society estimate , there will be more than 241,000 new cases of prostate cancer in the United States in 2012 .", "label": "", "metadata": {}, "score": "82.0315"}
{"text": "Stereotactic Body Radiation Therapy for Prostate Cancer .Stereotactic Body Radiation Therapy ( SBRT ) involves an ultra - abbreviated treatment regimen of 5 or fewer fractions administered using image guidance and precise treatment delivery techniques .", "label": "", "metadata": {}, "score": "82.34265"}
{"text": "This work has been supported in part by an Investigator - Initiated Research Grant from Nucletron B.V. , Veenendaal , The Netherlands .Competing interests .", "label": "", "metadata": {}, "score": "82.73654"}
{"text": "View Article .van Andel G , Bottomley A , Fossa SD , Efficace F , Coens C , Guerif S , Kynaston H , Gontero P , Thalmann G , Akdas A , et al .", "label": "", "metadata": {}, "score": "82.829315"}
{"text": "PubMed View Article .Wei JT , Dunn RL , Litwin MS , Sandler HM , Sanda MG : Development and validation of the expanded prostate cancer index composite ( EPIC ) for comprehensive assessment of health - related quality of life in men with prostate cancer .", "label": "", "metadata": {}, "score": "82.92195"}
{"text": "PubMed View Article .Horwitz EM , Levy LB , Thames HD , Kupelian PA , Martinez AA , Michalski JM , Pisansky TM , Sandler HM , Shipley WU , Zelefsky MJ , et al .", "label": "", "metadata": {}, "score": "82.9701"}
{"text": "NK cell activity was evaluated after 4 hr of incubation , and calculated as described previously [ 17 ] .Statistical analysis .We investigated all GI and GU toxicities ( late and acute ) separately .", "label": "", "metadata": {}, "score": "82.988304"}
{"text": "PubMed View Article .Van Lin EN , Hoffmann AL , van Kollenburg P , Leer JW , Visser AG : Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy .", "label": "", "metadata": {}, "score": "83.07585"}
{"text": "All treatments were completed within 10 days with a minimum of 12 hours between fractions .The planning target volume ( PTV ) was prostate only with 3 - 5 mm expansion .", "label": "", "metadata": {}, "score": "83.11862"}
{"text": "The group of Freeman and King used five fractions of 7 - 7.25 Gy first in daily fractions but later in every - other - day fractions [ 15 , 16 ] .", "label": "", "metadata": {}, "score": "83.12395"}
{"text": "However , it was discontinued after enrollment for patients with intermediate risk and continued for 2 years for those with high - risk .The clinical target volume ( CTV ) for intermediate - risk patients included the prostate and proximal seminal vesicles ( approximately 9 mm ) .", "label": "", "metadata": {}, "score": "83.39735"}
{"text": "Three - dimensional conformal radiotherapy ( 3DCRT ) represents one of the standard treatments of prostate cancer allowing the delivery of highly \" conformed \" ( focused ) radiation to the cancer cells , while significantly reducing the amount of radiation received by surrounding healthy tissue .", "label": "", "metadata": {}, "score": "83.446625"}
{"text": "Conclusion .There is a growing body of compelling evidence supporting the safety and efficacy of abbreviated radiotherapy schedules for prostate cancer .Especially provocative are the recent reports of contemporary clinical trials that utilized the latest planning , imaging , and delivery techniques .", "label": "", "metadata": {}, "score": "83.45169"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. M. Duchess and L. J. Peters , \" What is the \u03b1 / \u03b2 ratio for prostate cancer ?", "label": "", "metadata": {}, "score": "83.462555"}
{"text": "Patients and clinical protocol .Data for the study were collected from 245 consecutive patients with Stage T1 to T3 clinically localized prostate adenocarcinoma , treated with 3DCRT ( 2004 - 2009 ) at the Department of Radiotherapy and Oncology , Motol University Hospital , Prague , Czech Republic .", "label": "", "metadata": {}, "score": "83.50648"}
{"text": "191 - 195 , 1989 .View at Google Scholar \u00b7 View at Scopus . K. Haustermans and J. F. Fowler , \" A comment on proliferation rates in human prostate cancer , \" International Journal of Radiation Oncology Biology Physics , vol .", "label": "", "metadata": {}, "score": "83.798546"}
{"text": "All authors have read and approved the final manuscript .Authors ' Affiliations .Department of Medical Biophysics and Medical Informatics , 3rd Faculty of Medicine , Charles University .", "label": "", "metadata": {}, "score": "83.97452"}
{"text": "Prostate cancer LDR - brachytherapy GU toxicity GI toxicity .Background .On the other hand , genitourinary ( GU ) toxicity and gastrointestinal ( GI ) toxicity are important distress factors associated with LDR - brachytherapy .", "label": "", "metadata": {}, "score": "84.027985"}
{"text": "Radiother Oncol 2002 , 64 : 1 - 12 .PubMed View Article .Int J Radiat Oncol Biol Phys 2005 , 62 : 1297 - 1308 .", "label": "", "metadata": {}, "score": "84.09563"}
{"text": "of the surrounding normal tissues ( bladder and rectum ) , then hypofractionated regimens should result in an improved therapeutic outcome .There is now convincing evidence that biochemical control is improved with higher cumulative radiation doses to the prostate .", "label": "", "metadata": {}, "score": "84.46447"}
{"text": "Conclusion .Our RT series included 197 patients who were treated in one center and may serve as a basis for comparison with other oncology centers , particularly in the Czech Republic .", "label": "", "metadata": {}, "score": "84.514465"}
{"text": "Fowler JF : The radiobiology of prostate cancer including new aspects of fractionated radiotherapy .Acta Oncol 2005 , 44 : 265 - 276 .PubMed View Article .", "label": "", "metadata": {}, "score": "84.548706"}
{"text": "To report the clinical outcome of high dose rate brachytherapy as sole treatment for clinically localised prostate cancer .Methods .Between March 2004 and January 2008 , a total of 351 consecutive patients with clinically localised prostate cancer were treated with transrectal ultrasound guided high dose rate brachytherapy .", "label": "", "metadata": {}, "score": "84.79776"}
{"text": "( Daily enemas were not required during treatment , however , instructions to arrive with an empty rectum and full bladder were reinforced ) .Patients were immobilized supine with Knee - Lok and Foot - Lok cushions ( CIVCO , Orange City , IA ) , and an indexed lumen , 9 cm ERB ( RadiaDyne , LLC , Houston , TX ) was inserted into the rectum and filled with 100 mL of water .", "label": "", "metadata": {}, "score": "84.98332"}
{"text": "Pelvic bone marrow definition .For each patient , the pelvic bone marrow ( PBM ) volume was first defined according to the method described by Mell et al .", "label": "", "metadata": {}, "score": "85.0234"}
{"text": "Furthermore , this gives us the opportunity to shape the dose distribution in the critical area of the prostate to giver higher dose in the entire peripheral zone of the prostate where almost 65 % of prostate tumors were found in prostatectomy specimens [ 24 ] .", "label": "", "metadata": {}, "score": "85.32011"}
{"text": "From July 2004 to April 2007 , seed implantation was performed after preplanning by modified peripheral loading techniques using a Mick 's applicator [ 14 ] .", "label": "", "metadata": {}, "score": "85.602325"}
{"text": "PubMed View Article .Cancer Therapy Evaluation Program : Common terminology criteria for adverse events , version 3.0 .Division of Cancer Treatment and Diagnosis , National Cancer Institute , National Institutes of Health , Department of Health and Human Services , Washington , DC ; 2006 .", "label": "", "metadata": {}, "score": "85.60247"}
{"text": "In the high - risk patients , separate CTV and PTV were designed to treat the distal portions of the seminal vesicles , periprostatic , periseminal vesicle , external iliac , obturator , and internal iliac lymph nodes .", "label": "", "metadata": {}, "score": "85.936195"}
{"text": "Declarations .Competing interests .The author(s ) declare that they have no competing interests .Authors ' contributions .CD , NV , SB , and ZT conceived of the study , and participated in its design and coordination and helped to draft the manuscript .", "label": "", "metadata": {}, "score": "86.00055"}
{"text": "Other investigators have used similar 3 Gy per fractions in hypofractionated treatments .The clinical target volume includes the prostate and a base of seminal vesicles .", "label": "", "metadata": {}, "score": "86.031624"}
{"text": "IMRT plans provided excellent coverage , with all plans achieving target coverage goals .No hot spots were located within the OAR or OAR - target volume interfaces .", "label": "", "metadata": {}, "score": "86.069336"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. G. Dale and B. Jones , \" Is the \u03b1 / \u03b2 for prostate tumors really low ?", "label": "", "metadata": {}, "score": "86.281845"}
{"text": "Because of our short FU , the final nadir may not yet been reached .Other SBRT series have reported lower PSA nadirs after longer follow - up [ 15 , 16 ] .", "label": "", "metadata": {}, "score": "86.52752"}
{"text": "GI and GU toxicity evolution after WP and PO 3DCRT techniques .The used 3DCRT technique was proven as an important factor influencing the development of GI and GU toxicity .", "label": "", "metadata": {}, "score": "86.67461"}
{"text": "Department of Radiation Oncology and Stereotactic Radiotherapy , Medical School , University of Patras , 26504 Patras , Greece .Received 16 April 2012 ; Accepted 15 June 2012 .", "label": "", "metadata": {}, "score": "87.03785"}
{"text": "Presenter : J.M. Michalski Affiliation : Radiation Therapy Oncology Group .Background : .Randomized data have been reported that show improvements in biochemical outcomes for high risk prostate cancer patients treated with 3D conformal dose escalation .", "label": "", "metadata": {}, "score": "87.18085"}
{"text": "Androgen - deprivation therapy ( ADT ) was used at the discretion of the treating physician .ADT primarily consisted of an oral anti - androgen and luteinizing hormone - releasing hormone agonist administered as depot injections .", "label": "", "metadata": {}, "score": "87.32776"}
{"text": "PubMed View Article .Int J Radiat Oncol Biol Phys 2008 , 70 : 1130 - 1137 .PubMed View Article .Radiother Oncol 2009 , 93 : 197 - 202 .", "label": "", "metadata": {}, "score": "87.440094"}
{"text": "Rectal balloon IMRT Toxicity Prostate cancer .Introduction .Dose - escalated radiotherapy ( RT ) as radical treatment for clinically localized prostate cancer is well - established .", "label": "", "metadata": {}, "score": "87.60921"}
{"text": "All authors read and approved the final manuscript .Authors ' Affiliations .Department of Radiation Oncology , Klinikum Offenbach .Department of Urology , Klinikum Offenbach .", "label": "", "metadata": {}, "score": "88.03662"}
{"text": "Modern RTechniques including three - dimensional conformal ( 3DCRT ) , intensity modulated ( IMRT ) , proton therapy , and daily image guidance ( IG ) have allowed for more conformal prostate dose distributions with improved normal tissue sparing .", "label": "", "metadata": {}, "score": "88.13167"}
{"text": "IMRT plans were generated using 7 - 9 coplanar fields ( at least 4 of which were posterior oblique fields traveling through the rectum ) with 6 and/or 15 MV photon beams .", "label": "", "metadata": {}, "score": "88.15454"}
{"text": "Using the anatomy - based optimisation tool of SWIFT the dwell times were automatically adjusted ensuring the resulted 3D dose distribution fulfilled our PTV coverage requirements in compliance with OAR dose constraints ( Figure 1 b ) .", "label": "", "metadata": {}, "score": "88.52806"}
{"text": "PV : .Prostate volume .Declarations .Competing interests .The authors declare that they have no competing interests .Authors ' contributions .TN , FK , and HM conceived of this study .", "label": "", "metadata": {}, "score": "89.035"}
{"text": "The prostate and proximal two - thirds of the seminal vesicles were outlined by the physician and identified as the clinical target volume ( CTV ) .", "label": "", "metadata": {}, "score": "89.07295"}
{"text": "The GU toxicity profile of prostate IMRT using an ERB H2O is not expected to vary from ERB air and non - ERB prostate IMRT , as the dose distribution to the bladder is not significantly altered with ERB use .", "label": "", "metadata": {}, "score": "89.3361"}
{"text": "10 , pp .2832 - 2848 , 2003 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .57 , no . 2 , pp .", "label": "", "metadata": {}, "score": "89.56546"}
{"text": "In patients with clinically localised prostate cancer , high dose rate ( HDR ) brachytherapy ( BRT ) has emerged as a safe and effective monotherapeutic modality [ 1 - 8 ] .", "label": "", "metadata": {}, "score": "89.572655"}
{"text": "Department of Radiation Oncology .Department of Biostatistics & Epidemiology , University of Pennsylvania .Perelman School of Medicine , Department of Radiation Oncology , University of Pennsylvania .", "label": "", "metadata": {}, "score": "90.10724"}
{"text": "FK and HA helped to draft the manuscript .TN carried out the statistical analysis .All authors read and approved the final manuscript .Authors ' Affiliations .", "label": "", "metadata": {}, "score": "90.180016"}
{"text": "The median age , PSA value at diagnosis , and follow - up period were 68.7 years ( range : 51 - 80 ) , 8.7 ng / mL ( range : 3.1 - 32.1 ) , and 42.5 months ( range : 1 - 72 ) , respectively .", "label": "", "metadata": {}, "score": "90.33112"}
{"text": "Potency was defined as the ability to achieve an erection that was sufficient for intercourse .The estimated likelihood of events was calculated using the Kaplan - Meier method and comparisons made using the log - rank test .", "label": "", "metadata": {}, "score": "90.40588"}
{"text": "Authors ' Affiliations .Department of Radiation Oncology , Erasmus MC - Daniel den Hoed Cancer Center .Departmentv of Urology , Erasmus MC - Daniel den Hoed Cancer Center .", "label": "", "metadata": {}, "score": "90.40654"}
{"text": "5 , pp .1035 - 1041 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .65 , no .", "label": "", "metadata": {}, "score": "90.51674"}
{"text": "5 , pp .1035 - 1041 , 1997 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .51 , no .", "label": "", "metadata": {}, "score": "90.60626"}
{"text": "Prostate and organs at risk ( OAR , i.e. , rectum , urethra , bladder ) contouring was checked and updated according to the new acquired image set .", "label": "", "metadata": {}, "score": "90.87894"}
{"text": "The surface expression or extracellular release of stress proteins ( e.g. MICs , Hsp70 ) , following tumor cell damage by RT , can play a key role in immune system modulation [ 38 ] .", "label": "", "metadata": {}, "score": "91.05164"}
{"text": "Declarations .Competing interests .The authors declare that they have no competing interests .Authors ' Affiliations .Department of Radiological Technology , School of Health Sciences , Faculty of medicine , Tohoku University .", "label": "", "metadata": {}, "score": "91.18468"}
{"text": "We have no personal or financial conflicts of interest , and have not entered into any agreement that could interfere with our access to the data on the research , or upon our ability to analyze the data independently , to prepare manuscripts , and to publish them .", "label": "", "metadata": {}, "score": "91.29521"}
{"text": "4 , pp .234 - 239 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .52 , no . 1 , pp .", "label": "", "metadata": {}, "score": "91.31021"}
{"text": "10 , pp .729 - 737 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .73 , no .", "label": "", "metadata": {}, "score": "91.44289"}
{"text": "Department of Radiation Oncology , Nara Medical University .Department of Pathology , Nara Medical University .Department of Urology , Nara Medical University .References .", "label": "", "metadata": {}, "score": "91.57908"}
{"text": "988 - 993 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .68 , no .5 , pp .", "label": "", "metadata": {}, "score": "91.79967"}
{"text": "74 , no .4 , pp .1121 - 1127 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "92.21149"}
{"text": "Copyright .\u00a9 Vranova et al ; licensee BioMed Central Ltd. 2011 .Abstract .Background .Several studies have confirmed the advantages of delivering high doses of external beam radiotherapy to achieve optimal tumor - control outcomes in patients with localized prostate cancer .", "label": "", "metadata": {}, "score": "92.57071"}
{"text": "44 , no .4 , pp .747 - 748 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "92.76425"}
{"text": "Transrectal ultrasound .TURP : .Transurethral resection of the prostate .US : .Ultrasound .3D : . three - dimensional .Declarations .", "label": "", "metadata": {}, "score": "93.23102"}
{"text": "965 - 974 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .67 , no .4 , pp .", "label": "", "metadata": {}, "score": "93.91022"}
{"text": "24 - 33 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .82 , no . 1 , pp .", "label": "", "metadata": {}, "score": "93.95706"}
{"text": "Competing interests .The authors declare that they have no competing interests .Authors ' contributions .All authors approved this version to be published .", "label": "", "metadata": {}, "score": "94.28103"}
{"text": "Department of Immunology and Gnotobiology , Institute of Microbiology , Academy of Sciences of the Czech Republic , v.v.i .Faculty of Biomedical Engineering , Czech Technical University in Prague .", "label": "", "metadata": {}, "score": "94.45717"}
{"text": "RP / TURP : . radical prostatectomy / transurethral resection .RT : . radiotherapy .RTOG : .Radiation Therapy Oncology Group .WP : . whole pelvic .", "label": "", "metadata": {}, "score": "94.55058"}
{"text": "PubMed View Article .Brachytherapy 2008 , 7 : 7 - 11 .PubMed View Article .Copyright .\u00a9 Tselis et al . ; licensee BioMed Central Ltd. 2013 .", "label": "", "metadata": {}, "score": "94.69295"}
{"text": "The scientific rationale for such \" hypofractionated \" treatment lies in the unique radiobiologic properties of prostate cancer .Radiobiologic Rationale .The radiobiological basis of hypofractionation for prostate cancer assumes that the prostate cancer cells respond to radiotherapy in a manner that can be mathematically modeled with a classic linear - quadratic equation : . , represent linear and quadratic components of the equation [ 6 ] .", "label": "", "metadata": {}, "score": "95.13188"}
{"text": "36 , no . 2 , pp .107 - 111 , 1990 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "95.623795"}
{"text": "The rectal wall was defined with a 2-mm internal wall extraction .The bladder was entirely contoured , and a 5-mm inner wall defined the bladder wall volume .", "label": "", "metadata": {}, "score": "95.94066"}
{"text": "In the IMRT planning , Eclipse ( release 6.5 ; Varian medical Systems , Palo Alto , CA , USA ) was used for dose calculations .", "label": "", "metadata": {}, "score": "96.00282"}
{"text": "To adequately encompass the extent of tumor invasion in the seminal vesicles , the CTV involved the base of the seminal vesicles in T1 - 3a patients and more distal to entire portion of the seminal vesicles in T3b patients , respectively .", "label": "", "metadata": {}, "score": "96.87906"}
{"text": "Department of Radiation Oncology , Sendai medical Center .Sendai Radiation Oncology and Imaging Clinic .Department of Radiation Oncology , Tohoku University Hospital .Department of Urology , Tohoku University Hospital .", "label": "", "metadata": {}, "score": "97.4839"}
{"text": "228 - 234 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .63 , no .5 , pp .", "label": "", "metadata": {}, "score": "97.62274"}
{"text": "Conclusions .Our results confirm high dose rate brachytherapy as safe and effective monotherapy for clinically organ - confined prostate cancer .Keywords .Prostate cancer Brachytherapy High dose rate Iridium Monotherapy .", "label": "", "metadata": {}, "score": "98.01293"}
{"text": "Acknowledgements .We thank Drs .Bela Malinova , Anna Kindlova , Jana Prausova , and Michaela Matouskova for excellent cooperation and valuable comments .The work was supported by the Grant agency of the Charles University , GAUK 109908/2008 and the Grant agency of the Academy of Sciences of the Czech Republic , IAA500200620 .", "label": "", "metadata": {}, "score": "98.31648"}
{"text": "The planning target volume ( PTV ) was defined as the entire prostate gland without margins .Based on the acquired 3D anatomy , the appropriate virtual needle positions were generated using the intraoperative treatment planning system SWIFT ( Nucletron B.V. , Veenendaal , The Netherlands ) .", "label": "", "metadata": {}, "score": "101.74472"}
{"text": "4 , pp .1072 - 1083 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .View at Google Scholar .", "label": "", "metadata": {}, "score": "106.167496"}
{"text": "PubMed View Article .Copyright .\u00a9 Deville et al . ; licensee BioMed Central Ltd. 2012 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "109.86168"}
{"text": "J Clin Oncol 2011 , 29 : 2020 - 2026 .PubMed View Article .Copyright .\u00a9 aluwini et al . ; licensee BioMed Central Ltd. 2013 .", "label": "", "metadata": {}, "score": "110.41838"}
{"text": "PubMed View Article .Copyright .\u00a9 Takeda et al . ; licensee BioMed Central Ltd. 2012 .This article is published under license to BioMed Central Ltd. Abstract .", "label": "", "metadata": {}, "score": "111.54927"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .68 , no .5 , pp .1424 - 1430 , 2007 .", "label": "", "metadata": {}, "score": "113.954056"}
{"text": "PubMed View Article .Copyright .\u00a9 Tanaka et al . ; licensee BioMed Central Ltd. 2013 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "114.08877"}
{"text": "This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "118.57324"}
{"text": "This is an open access article distributed under the Creative Commons Attribution License , which permits unrestricted use , distribution , and reproduction in any medium , provided the original work is properly cited .", "label": "", "metadata": {}, "score": "118.57324"}
{"text": "Chicago .Arcangeli , Stefano , Lidia Strigari , Guy Soete , Gert De Meerleer , Sara Gomellini , Val\u00e9rie Fonteyne , Guy Storme , and Giorgio Arcangeli . \"", "label": "", "metadata": {}, "score": "122.87207"}
{"text": "View at Google Scholar .81 , pp .1271 - 1278 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "124.17112"}
{"text": "View at Google Scholar \u00b7 View at Scopus .52 , no . 1 , pp .6 - 13 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "127.420044"}
